| Patent application number | Description | Published |
|---|
| 20080199060 | Distortion compensated imaging - Certain aspects can relate to responsive to the at least some input compensating information, imaging the at least the portion of the individual in a manner to limit at least some distorting effects of the at least the portion of the at least one distorting feature associated with the at least the portion of the individual at least partially by modifying a non-optical electromagnetic output from an imaging modality as applied to the at least the portion of the at least one distorting feature associated with the at least the portion of the individual. Certain aspects can relate to creating at least one conformal absence of a non-optical electromagnetic output to limit distortion to an imaging of an at least a portion of an individual resulting at least partially from at least one distorting feature associated with the at least the portion of the individual. | 08-21-2008 |
| 20080201007 | Methods and systems for making a blood vessel sleeve - Methods, apparatuses, computer program products, devices and systems are described that include accepting one or more blood vessel sleeve dimensions based on blood vessel data from an individual; and making a rapid-prototyped blood vessel sleeve at least partly based on the one or more blood vessel sleeve dimensions. | 08-21-2008 |
| 20080207983 | Coded-sequence activation of surgical implants - Implants responsive to spatiotemporal signal sequences, and methods of operating implants by transmitting spatiotemporal signal sequences. | 08-28-2008 |
| 20080208010 | Coded-sequence activation of surgical implants - Implants responsive to spatiotemporal signal sequences, and methods of operating implants by transmitting spatiotemporal signal sequences. | 08-28-2008 |
| 20080210882 | Multi-stage waveform detector - A waveform detector may include multiple stages. | 09-04-2008 |
| 20080216826 | Airway imaging system - Embodiments include a medical device, an apparatus, and a method. The medical device includes a tube portion shaped and sized for airway passage insertion and having at least one pathway therethrough; and a stylet of at least one shape-transforming material, configured for insertion in one of said at least one pathway; and at least one sensor carried by the tube portion and the stylet. The apparatus includes a stylet having a first end and a second end, at least a portion of the stylet including a shape-transforming material, the stylet being configured for insertion through an airway intubation structure having at least one pathway therethrough; and at least one sensor carried by the stylet in a proximity to the first end. The method includes capturing an image adjacent to an airway tube proximate to an airway passage; and actuating, in response to the image, at least one shape-transformation of the airway tube. | 09-11-2008 |
| 20080216840 | Imaging via the airway - Embodiments include a medical device, an apparatus, and a method. The medical device includes a tube portion shaped and sized for airway passage insertion and having at least one pathway therethrough; and a stylet of at least one shape-transforming material, configured for insertion in one of said at least one pathway; and at least one sensor carried by the tube portion and the stylet. The apparatus includes a stylet having a first end and a second end, at least a portion of the stylet including a shape-transforming material, the stylet being configured for insertion through an airway intubation structure having at least one pathway therethrough; and at least one sensor carried by the stylet in a proximity to the first end. The method includes capturing an image adjacent to an airway tube proximate to an airway passage; and actuating, in response to the image, at least one shape-transformation of the airway tube. | 09-11-2008 |
| 20080232535 | Modular nuclear fission reactor - Illustrative embodiments provide modular nuclear fission deflagration wave reactors and methods for their operation. Illustrative embodiments and aspects include, without limitation, modular nuclear fission deflagration wave reactors, modular nuclear fission deflagration wave reactor modules, methods of operating a modular nuclear fission deflagration wave reactor, and the like. | 09-25-2008 |
| 20080240333 | Nuclear fission igniter - Illustrative embodiments provide nuclear fission igniters for nuclear fission reactors and methods for their operation. Illustrative embodiments and aspects include, without limitation, a nuclear fission igniter configured to ignite a nuclear fission deflagration wave in nuclear fission fuel material, a nuclear fission deflagration wave reactor with a nuclear fission igniter, a method of igniting a nuclear fission deflagration wave, and the like. | 10-02-2008 |
| 20080243056 | Controllable release nasal system - Embodiments of devices and system for controllable nasal delivery of materials are described. Methods of use of such devices and system and software for controlling the operation of such devices and systems are also disclosed. | 10-02-2008 |
| 20080253511 | Scintillator aspects of compton scattered X-Ray visualization, imaging, or information providing - One aspect relates to visualizing, imaging, or providing information at least partially through at least some matter of an at least a portion of an individual, based at least in part on Compton scattering to at least partially form scattered X-rays, the Compton scattering occurring primarily in the at least some matter of the at least the portion of the individual, wherein the visualizing, imaging, or providing information is at least partially performed by converting the scattered X-rays into an at least one scintillated viewable and/or visible light that is detectable by a user. Another aspect relates to Compton scattered X-ray based visualizing, imaging, or providing information of an at least some matter of an at least a portion of an at least one individual to allow the at least one individual and/or an untrained assistant to at least partially visualize, image, or provide information into the at least some matter of the at least the portion of the individual based at least partially on Compton scattered X-rays. | 10-16-2008 |
| 20080253513 | Compton scattered X-ray visualization, imaging, or information provider in soft matter such as tissue, organs, or blood, and/or in hard matter such as bones or teeth - One aspect relates to visualizing, imaging, or providing information of an at least some tissue-based matter or bone-based matter of an at least a portion of an individual at least partially through at least one range of visualizing, imaging, or providing information depth to at least one prescribed visualizing, imaging, or providing information depth of the at least some tissue-based matter or bone-based matter of the at least the portion of the individual, at least partially dependent on an at least one applied characteristic of an at least one applied X-ray being applied to the at least some of the at least some tissue-based matter or bone-based matter of the at least the portion of the individual. | 10-16-2008 |
| 20080253520 | Compton scattered X-ray visualization, imaging, or information provider with scattering event locating - One aspect relates to determining a location of an at least one scattering event occurring within an at least some matter of at least a portion of an individual, wherein the determining the location of the the at least one scattering event is based at least in part on a combination of: a relative position and/or angle at which an at least one applied X-ray being applied to the at least some matter of the at least the portion of the individual, an applied energy level of the at least one applied X-ray being applied to the at least some matter of the at least the portion of the individual, a detected location of an at least one scattered X-ray resulting from scattering of the at least one applied X-ray scattering during the at least one scattering event, and a scattered energy level of the at least one scattered X-ray. | 10-16-2008 |
| 20080253521 | Compton scattered X-ray visualization, imaging, or information provider with time of flight computation - One aspect relates to locating an at least one scattering event at least partially within an at least some matter of an at least a portion of an individual at least partially by directing an at least one pulse-type applied X-ray at the at least some matter of the at least the portion of the individual to create an at least one corresponding pulse-type Compton scattered X-ray, wherein the locating the at least one scattering event is based at least in part on an at least one time of flight computation derived at least in part from a combination of an at least one applied duration and an at least one scattered duration, wherein the at least one applied duration corresponds to a time for the at least one pulse-type applied X-ray to reach the at least one scattering event within the at least some matter of the at least the portion of the individual, and further wherein the at least one scattered duration corresponds to a time for the at least one corresponding pulse-type Compton scattered X-ray to thereupon travel from the at least one scattering event within the at least some matter of the at least the portion of the individual to be detected. | 10-16-2008 |
| 20080253522 | Tool associated with compton scattered X-ray visualization, imaging, or information provider - One aspect relates to providing an at least one Compton scattered X-ray visualizing, imaging, or information providing operation relative to at least one visualizing, imaging, or information providing region within an at least some matter of an at least a portion of an individual; and providing a tool-based operation to at least the portion of the at least one visualizing, imaging, or information providing region within the at least some matter of the at least the portion of the individual based at least partially on the providing the at least one Compton scattered X-ray visualizing, imaging, or information providing operation relative to the at least the portion of the at least one visualizing, imaging, or information providing region. | 10-16-2008 |
| 20080253523 | Compton scattered X-ray depth visualization, imaging, or information provider - One aspect relates to at least a portion of at least one Compton scattered X-ray visualizer, imager, or information provider configured to receive an at least one Compton scattered X-ray that has scattered through a substantial scattering depth range to one or more substantial prescribed scattering depths within an at least one matter of an at least a portion of an individual based at least in part on a set of scattering characteristics, the set of scattering characteristics at least partially corresponding to the at least one matter of the least the portion of the individual; the at least the portion of the at least one Compton scattered X-ray visualizer, imager, or information provider being configured for providing an at least one Compton scattered X-ray visualization, imaging, or information providing through one or more visualization, imaging, or information providing depth ranges to one or more visualization, imaging, or information providing prescribed depths into the at least one matter of the least the portion of the individual. | 10-16-2008 |
| 20080253524 | Method and system for Compton scattered X-ray depth visualization, imaging, or information provider - One aspect relates to at least a portion of at least one Compton scattered X-ray visualizer, imager, or information provider configured to receive an at least one Compton scattered X-ray that has scattered through a substantial scattering depth range to one or more substantial prescribed scattering depths within an at least one matter of an at least a portion of an individual based at least in part on a set of scattering characteristics, the set of scattering characteristics at least partially corresponding to the at least one matter of the least the portion of the individual; the at least the portion of the at least one Compton scattered X-ray visualizer, imager, or information provider being configured for providing an at least one Compton scattered X-ray visualization, imaging, or information providing through one or more visualization, imaging, or information providing depth ranges to one or more visualization, imaging, or information providing prescribed depths into the at least one matter of the least the portion of the individual. | 10-16-2008 |
| 20080253525 | Compton scattered x-ray visualizing, imaging, or information providing of at least some dissimilar matter - One aspect relates to Compton Scattered X-ray visualizing, imaging, or providing information at least partially through an at least some matter of an at least a portion of an individual through an at least one prescribed visualizing, imaging, or information providing depth based at least partially on a density differentiation between the at least some matter of the at least the portion of the individual and at least some dissimilar matter of the at least the portion of the individual, wherein the Compton Scattered X-ray visualizing, imaging, or providing information is at least partially dependent on an at least one applied characteristic of an at least one applied X-ray being applied to the at least some matter of the at least the portion of the individual and the at least some matter of the at least the portion of the individual, and thereupon the at least one applied X-ray undergoes Compton Scattering within the at least some matter of the at least the portion of the individual in a manner that density differentiates the at least some matter of the at least the portion of the individual with respect to the at least some matter of the at least the portion of the individual. | 10-16-2008 |
| 20080253526 | Geometric compton scattered x-ray visualizing, imaging, or information providing - Certain aspects relate to determining a location that an at least one Compton Scattered X-ray event occurs within an at least some matter of at least a portion of an individual based at least in part on determining a relative angle at which an at least one applied X-ray is being applied to the at least some matter of the at least the portion of the individual, determining a relative position from which an at least one applied X-ray is being applied to the at least some matter of the at least the portion of the individual. Certain aspects can include determining a detected location at which at least one induced Compton scattered X-ray photon is detected following scattering at the at least one Compton Scattered X-ray event, and determining a received angle at which the at least one induced Compton scattered X-ray photon is received following scattering at the at least one Compton Scattered X-ray event. | 10-16-2008 |
| 20080253527 | Limiting compton scattered x-ray visualizing, imaging, or information providing at particular regions - One aspect relates to Compton X-ray scattering visualizing, imaging, or information providing within an at least some matter of an at least a portion of an individual to an at least one prescribed desired application regions within the at least some matter of the at least the portion of the individual based at least partially on an inducing of at least one induced Compton X-ray scattering photon within the at least some matter of the at least the portion of the individual responsive to an at least some applied X-rays being applied to the at least some matter of the at least the portion of the individual, wherein the Compton X-ray scattering visualizing, imaging, or information providing is limited to an at least one prescribed desired radiation protected region within the at least some matter of the at least the portion of the individual based at least partially on a limiting of an inducing of at least one induced Compton X-ray scattering photon within the at least one prescribed desired radiation protected region. | 10-16-2008 |
| 20080253528 | Low invasive technique using compton scattered x-ray visualizing, imaging, or information providing to differentiate at least some dissimilar matter - One aspect relates to ablating an at least some matter of an at least a portion of an individual within an at least one prescribed desired ablating region at least partially responsive to at least some Compton X-ray scattering visualizing, imaging, or information providing within the at least some matter of the at least the portion of the individual that is performed at least partially through a substantial depth through the at least some matter of the at least the portion of the individual. Certain aspects can include locating an at least one prescribed desired ablating region within the at least some matter of the at least the portion of the individual at least partially responsive to the Compton X-ray scattering visualizing, imaging, or information providing within the at least some matter of the at least the portion of the individual. | 10-16-2008 |
| 20080253529 | Ablating based at least partially on compton scattered x-ray visualizing, imaging, or information providing - Certain aspects relate to determining a desired ablating region within the at least some matter of the at least the portion of the individual at least partially in response to a Compton X-ray scattering visualizing, imaging, or information providing within the at least some matter of the at least the portion of the individual. Certain aspects can include ablating at least a portion of a desired ablating region within at least a portion of an at least some matter of an at least a portion of an individual based at least partially on a determining the desired ablating region within the at least some matter of the at least the portion of the individual responsive to the Compton X-ray scattering visualizing, imaging, or information providing within the at least some matter of the at least the portion of the individual. | 10-16-2008 |
| 20080253530 | Limiting ablation based at least partially on Compton scattered X-ray visualizing, imaging, or information providing - Certain aspects relate to locating an at least some matter of at least a portion of an individual within an at least one prescribed desired ablating region at least partially responsive to a Compton X-ray scattering visualizing, imaging, or information providing within the at least some matter of the at least the portion of the individual. Certain aspects relate to ablating the at least some matter of the at least the portion of the individual within the at least one prescribed desired ablating region at least partially responsive to a locating the at least some matter of the at least the portion of the individual within the at least one prescribed desired ablating region, in a manner that limits effects of the ablating to the at least some matter of the at least the portion of the individual at regions outside of the at least one prescribed desired ablating region based at least partially on the locating the at least one prescribed desired ablating region at least partially responsive to the locating the at least some matter of the at least the portion of the individual within the at least one prescribed desired ablating region. | 10-16-2008 |
| 20080253531 | Cauterizing based at least partially on Compton scattered x-ray visualizing, imaging, or information providing - Certain aspects relate to locating an at least one prescribed desired cauterizing region within an at least some matter of an at least a portion of an individual at least partially responsive to a Compton X-ray scattering visualizing, imaging, or information providing of the at least some matter of the at least the portion of the individual. Certain aspects relate to cauterizing the at least some matter of the at least the portion of the individual within the at least one prescribed desired ablating region at least partially responsive to the locating the at least one prescribed desired cauterizing region within the at least some matter of the at least the portion of the individual, at least partially response to the locating the at least one prescribed desired cauterizing region within the at least some matter of the at least the portion of the individual. | 10-16-2008 |
| 20080253627 | Compton scattered X-ray visualization, imaging, or information provider using image combining - One aspect relates to deriving at least one first visualization, image, or provided information via Compton scattering substantially within an at least some matter of an at least a portion of an individual at least partially as a result of directing an at least one first applied X-ray having an at least one first energy level towards the at least some matter of the at least the portion of the individual; deriving at least one second visualization, image, or provided information via Compton scattering substantially within the at least some matter of the at least the portion of the individual at least partially as a result of directing an at least one second applied X-ray having an at least one second energy level toward the at least some matter of the at least the portion of the individual; and deriving at least one combined visualization, combined image, or combined provided information at least partially by combining the at least one first visualization, image, or provided information with the at least one second visualization, image, or provided information. | 10-16-2008 |
| 20080253637 | Volumetric type compton scattered X-ray visualization, imaging, or information provider - One aspect relates to capturing one or more tomographic-type Compton scattering based visualizations, images, or provided information of an at least some matter of at least a portion of an individual based at least partially on Compton scattering of an at least one X-ray being applied to the at least some matter of the at least the portion of the individual. Another aspect relates to deriving an at least one material characteristic distribution function that substantially fits at least some data obtained at least partially by scattering of an at least one applied X-ray within at least some matter of at least a portion of an individual to form at least one Compton scattered X-ray. | 10-16-2008 |
| 20080262341 | Active blood vessel sleeve methods and systems - Methods, apparatuses, computer program products, devices and systems are described that include accepting one or more blood vessel sleeve dimensions based on blood vessel data from an individual; and making a rapid-prototyped blood vessel sleeve at least partly based on the one or more blood vessel sleeve dimensions. | 10-23-2008 |
| 20080262390 | Fiducials for placement of tissue closures - Fiducial markings are placed on a patient to identify surgical parameters such as locations for an incision or a surgical closure. | 10-23-2008 |
| 20080262524 | Systems and methods for closing of fascia - An opening in a fascia is closed by inserting a cannula through the fascia, and attaching a tissue anchor to the fascia from the exterior or through a side of the cannula. | 10-23-2008 |
| 20080262540 | Systems and methods for approximating surfaces - Tissue is approximated by adhering anchors to opposing sides of a wound and coupling the anchors together. | 10-23-2008 |
| 20080262543 | Systems and methods for approximating surfaces - Tissue is approximated by adhering anchors to opposing sides of a wound and coupling the anchors together. | 10-23-2008 |
| 20080265135 | Multi-stage waveform detector - A waveform detector may include multiple stages. | 10-30-2008 |
| 20080283570 | Gentle touch surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical fasteners, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body organ/tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283571 | Sensing surgical fastener - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical fasteners by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical fasteners, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple or fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283572 | Surgical stapling instrument with chemical sealant - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical staples, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical staples containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283574 | Maneuverable surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one delivery mechanism adapted to deliver surgical fasteners, the delivery mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283576 | Surgical fastening device with cutter - Embodiments include a surgical device and a method. An embodiment of the surgical fastening device includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical fasteners by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical fasteners, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283577 | Steerable surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one delivery mechanism adapted to deliver surgical fasteners, the delivery mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body organ/tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-20-2008 |
| 20080283765 | Multi-stage waveform detector - A waveform detector may include multiple stages. | 11-20-2008 |
| 20080287987 | Dispensing system for tissue sealants - The present invention discloses a medical device comprising a dispenser adapted to dispense a tissue sealant or one or more precursor compounds, the dispenser being operably coupled to a surgical stapler, which in turn is configured to deliver one or more surgical staples or fasteners in an area of bodily tissue approximation surface. Furthermore, the medical device comprises a dispenser adapted to dispense a tissue sealant or one or more precursor compounds thereof, the dispenser being operably coupled to a surgical cutter. Additionally or alternatively the medical; device can include a microactuation mechanism, whereby the dispenser dispenses the tissue sealant or one or more precursor compounds at a surgical cutting site or in a proximity thereof. | 11-20-2008 |
| 20080293050 | Gene analysis for determination of a treatment characteristic - An apparatus, device, methods, computer program product, and systems are described that determine at least one amino acid sequence alteration of an amino acid sequence of a disease associated polypeptide, relative to an amino acid sequence of a corresponding non-disease associated polypeptide, identify a sub-sequence in the amino acid sequence of the disease associated polypeptide in which the amino acid sequence alteration occurs, relate the sub-sequence in the amino acid sequence of the disease associated polypeptide to a corresponding sub-sequence of the amino acid sequence of the corresponding non-disease associated polypeptide, and determine a treatment characteristic, based on the relating. | 11-27-2008 |
| 20080302971 | Variable multi-stage waveform detector - A variable waveform detector may include multiple stages. | 12-11-2008 |
| 20090005727 | Acoustically controlled substance delivery device - Embodiments of a system including a remotely controlled substance delivery device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, a delivery device or related device may be placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. The concentration of a substance in the fluid to be delivered may be modified by a remote control signal. In selected embodiments, an acoustic control signal may be used. | 01-01-2009 |
| 20090007422 | Connectible nanotube circuit - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 01-08-2009 |
| 20090008567 | Variable multi-stage waveform detector - A variable waveform detector may include multiple stages. | 01-08-2009 |
| 20090018704 | Method and system for control of osmotic pump device - Embodiments of a system including a remotely controlled osmotic pump device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, an osmotic pump device is placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the osmotic pump device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. In selected embodiments, a magnetic field, an electric field, or electromagnetic control signal may be used. | 01-15-2009 |
| 20090022666 | Methods and systems relating to mitochondrial DNA information - The present application relates, in general, to a system or a method for detection or treatment. In some aspects, a system includes at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions including but not limited to one or more instructions for making at least one correlation between mitochondrial DNA information regarding at least one person and information regarding at least one clinical trial involving the at least one person. | 01-22-2009 |
| 20090024018 | Anatomical imaging system - Embodiments include a medical device, an apparatus, and a method. The medical device includes a tube portion shaped and sized for airway passage insertion and having at least one pathway therethrough; and a stylet of at least one shape-transforming material, configured for insertion in one of said at least one pathway; and at least one sensor carried by the tube portion and the stylet. The apparatus includes a stylet having a first end and a second end, at least a portion of the stylet including a shape-transforming material, the stylet being configured for insertion through an airway intubation structure having at least one pathway therethrough; and at least one sensor carried by the stylet in a proximity to the first end. The method includes capturing an image adjacent to an airway tube proximate to an airway passage; and actuating, in response to the image, at least one shape-transformation of the airway tube. | 01-22-2009 |
| 20090024114 | Method and system for control of osmotic pump device - Embodiments of a system including a remotely controlled osmotic pump device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, an osmotic pump device is placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the osmotic pump device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. In selected embodiments, a magnetic field, an electric field, or electromagnetic control signal may be used. | 01-22-2009 |
| 20090024140 | Surgical feedback system - The invention pertains to a surgical system. In an embodiment, the system comprises one or more sensors operably responsive to physical boundary limitations of an operating field. Furthermore, the one or more sensors provide information regarding the physical boundary limitations of the operating field. In another embodiment, the system comprises a surgical instrument that is configured to respond to the information by either activation or inactivation. In another aspect the invention includes generating an anatomical image or anatomic positional reference data. Additionally, the method includes creating haptic feedback signals based at least partly on the anatomical image or anatomic positional reference data, and determining a position or orientation of a surgical instrument. Furthermore the method includes activating or inactivating the surgical instrument based at least partly on the haptic feedback signals. | 01-22-2009 |
| 20090024152 | Custom-fitted blood vessel sleeve - Methods, apparatuses, computer program products, devices and/or systems are described that include a blood vessel sleeve that is custom-fitted for the outside of a blood vessel at least partly based on anatomical blood vessel data from an individual. | 01-22-2009 |
| 20090024329 | Methods and systems relating to epigenetic information - The present application relates, in general, to a system or method for detection or treatment. In some aspects, a system includes at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions including, but not limited to, one or more instructions for determining at least one correlation between at least one aspect of epigenetic information regarding at least one individual and information regarding at least one clinical outcome following receipt by the at least one individual of at least one medical therapy. | 01-22-2009 |
| 20090024330 | METHODS AND SYSTEMS RELATING TO EPIGENETIC PHENOTYPES - In one aspect, a system includes, but is not limited to, at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions, including but not limited to, one or more instructions for determining at least one correlation between at least one epigenetic-influencing event and at least one aspect of epigenetic phenotype information regarding at least one individual. | 01-22-2009 |
| 20090024333 | Methods and systems relating to mitochondrial DNA phenotypes - In one aspect, a system includes, but is not limited to, at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions, including but not limited to, one or more instructions for determining at least one correlation between at least one mitochondrial DNA-influencing event and at least one aspect of mitochondrial DNA phenotype information regarding at least one individual. | 01-22-2009 |
| 20090048648 | Self-sterilizing device - An insertable medical element may be supportive of evanescent energy for sterilization of a biomaterial. A system including an insertable medical element supportive of evanescent energy may include an energy source, where the energy source may be emissive of electromagnetic or plasmon energy, a sensor such as a surface plasmon resonance sensor, and/or it may include an imager. | 02-19-2009 |
| 20090054877 | Acoustically controlled substance delivery device - Embodiments of a system including a remotely controlled substance delivery device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, a delivery device or related device may be placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. The concentration of a substance in the fluid to be delivered may be modified by a remote control signal. In selected embodiments, an acoustic control signal may be used. | 02-26-2009 |
| 20090060287 | Physiological condition measuring device - A device is configured for one or more of communication transfer and audio/video playback. The device includes a sensing system for measuring a physiological condition through manipulation of an output of the device and analysis of a user response. | 03-05-2009 |
| 20090062686 | Physiological condition measuring device - A method may include providing an output comprising a presentation format to an end user. The output may be provided for user-based interaction. An interactive response from the end user may be measured in response to the presentation format of the output, where the interactive response may be indicative of at least one physiological condition regarding the end user. | 03-05-2009 |
| 20090071817 | Selective resonance of chemical structures - Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs. | 03-19-2009 |
| 20090076840 | Wireless ICU - A method may include receiving information from two or more wireless sensors and identifying patient identification information included in the information. | 03-19-2009 |
| 20090080587 | Nuclear fission igniter - Illustrative embodiments provide nuclear fission igniters for nuclear fission reactors and methods for their operation. Illustrative embodiments and aspects include, without limitation, a nuclear fission igniter configured to ignite a nuclear fission deflagration wave in nuclear fission fuel material, a nuclear fission deflagration wave reactor with a nuclear fission igniter, a method of igniting a nuclear fission deflagration wave, and the like. | 03-26-2009 |
| 20090080588 | Nuclear fission igniter - Illustrative embodiments provide nuclear fission igniters for nuclear fission reactors and methods for their operation. Illustrative embodiments and aspects include, without limitation, a nuclear fission igniter configured to ignite a nuclear fission deflagration wave in nuclear fission fuel material, a nuclear fission deflagration wave reactor with a nuclear fission igniter, a method of igniting a nuclear fission deflagration wave, and the like. | 03-26-2009 |
| 20090081800 | Selective resonance of chemical structures - Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs. | 03-26-2009 |
| 20090084951 | Scintillator aspects for X-Ray fluorescence visualizer, imager, or information provider - One aspect relates to optically detecting an at least one scintillated viewable and/or visible photon that has been converted from the at least one induced X-ray fluorescing photon. The aspect can also relate to optically detecting an at least one scintillated viewable and/or visible photon that has been converted from the at least one induced X-ray fluorescing photon. | 04-02-2009 |
| 20090086892 | Proximity-based X-ray fluorescence visualizer, imager, or information provider - One aspect relates to detecting at least one induced X-ray fluorescing photon fluoresced from substantially within an at least some matter of an at least a portion of an at least one individual at least partially as a result of receiving at least one induced X-ray fluorescing photon generated at least partially within at least one X-ray fluorescence event within the at least some matter of the at least the portion of the at least one individual which has been generated responsive to an at least some input energy resulting from a single input energy event, wherein the at least one induced X-ray fluorescing photon that has passed through the at least some matter of the at least the portion of the at least one individual is at a level to substantially limit interference between the at least one induced X-ray fluorescing photon with an at least one other induced X-ray fluorescing photon that travel for distances greater than a prescribed limit through the at least some matter of the at least the portion of the at least one individual, wherein the at least one other induced X-ray fluorescing photon attenuates by a prescribed percentage after passing through the prescribed distance through the at least some matter of the at least the portion of the at least one individual. | 04-02-2009 |
| 20090086893 | Combining X-Ray fluorescence visualizer, imager, or information provider - One aspect relates to deriving at least one first X-ray fluorescence visualization, image, or provided information substantially within an at least some matter of an at least a portion of an at least one individual at least partially as a result of directing an at least one first applied high energy photon and/or particle having an at least one first input energy towards the at least some matter of the at least the portion of the at least one individual. The aspect comprises deriving at least one second X-ray fluorescence visualization, image, or provided information substantially within the at least some matter of the at least the portion of the at least one individual at least partially as a result of directing an at least one second applied high energy photon and/or particle having an at least one second input energy toward the at least some matter of the at least the portion of the at least one individual. The aspect comprises deriving an at least one combined X-ray fluorescence visualization, combined image, or combined provided information at least partially by combining the at least one first X-ray fluorescence visualization, image, or provided information with the at least one second X-ray fluorescence visualization, image, or provided information. | 04-02-2009 |
| 20090086894 | Time of flight aspects for X-Ray fluorescence visualizer, imager, or information provider - One aspect can relate to determining a total time of flight that indicates an at least one applied duration and an at least one induced duration, wherein the at least one applied duration describes the time for an at least some pulse-type input energy to be applied from a transmission location to an at least one X-ray fluorescing event in the at least some matter of the at least the portion of the at least one individual, and wherein the at least one induced duration describes the time for an at least one induced X-ray fluorescing photon, to travel from the at least one X-ray fluorescing event in the at least some matter of the at least the portion of the at least one individual to a location where the at least one induced X-ray fluorescing photon is received at least partially by a detecting the at least one induced X-ray fluorescing photon. The aspect can relate to determining a location information of the at least one X-ray fluorescing event in the at least some matter of the at least the portion of the at least one individual based at least partially on the total time of flight. | 04-02-2009 |
| 20090086895 | Geometric X-Ray fluorescence visualizer, imager, or information provider - One aspect relates to determining a location of an at least one X-ray fluorescing event occurring within an at least some matter of at least a portion of an individual, wherein the determining the location of the at least one X-ray fluorescing event is based at least in part on determining a relative angle at which an at least one applied high energy photon and/or particle is being applied to the at least some matter of the at least the portion of the individual, a relative position from which an at least one applied high energy photon and/or particle is being applied to the at least some matter of the at least the portion of the individual, a detected location of an at least one induced fluorescing X-ray photon fluoresced during the at least one X-ray fluorescing event, and a received angle at which the at least one induced fluorescing X-ray photon is received. | 04-02-2009 |
| 20090086896 | Tool based X-ray fluorescence visualizing, imaging, or information providing - Certain embodiments of one aspect relates to inducing at least one induced X-ray fluorescing photon within an at least some matter of an at least a portion of an at least one individual responsive to an at least some input energy being applied to the at least some matter of the least the portion of the at least one individual. The aspect can include X-ray fluorescence visualizing, imaging, or information providing within the at least some matter of the least the portion of the at least one individual at least partially in response to the inducing at least one induced X-ray fluorescing photon within the at least some matter of the least the portion of the at least one individual. Certain embodiments of the aspect can include providing a substantial real time tool-based operation to the at least some matter of the least the portion of the at least one individual at least partially relying on the X-ray fluorescence visualizing, imaging, or information providing within the at least some matter of the least the portion of the at least one individual. | 04-02-2009 |
| 20090086899 | Repositioning X-ray fluorescence visualizer, imager, or information provider - One aspect can relate to performing a first X-ray fluorescence visualizing, imaging, or information providing within a first field of view in an at least some matter of an at least a portion of an at least one individual based on at least one induced fluorescing X-ray photon. The aspect can include operationally repositioning the first X-ray fluorescence visualizing, imaging, or information providing to X-ray fluorescence visualize, image, or information provide from within the first field of view to within a second field of view. The aspect can include performing a second X-ray fluorescence visualizing, imaging, or information providing within the second field of view within the at least some matter of the at least the portion of the at least one individual. | 04-02-2009 |
| 20090086900 | Portable aspects for x-ray fluorescence visualizer, imager, or information provider - One aspect relates to inducing at least one induced X-ray fluorescing photon at a X-ray fluorescence event within an at least some matter of an at least a portion of an at least one individual responsive to an at least some input energy being applied to the at least some matter of the at least the portion of the at least one individual. The aspect can include detecting the at least one induced X-ray fluorescing photon, wherein the inducing at least one induced X-ray fluorescing photon and the detecting the at least one induced X-ray fluorescing photon is configured to be transported portably as a self-contained and self-powered unit. | 04-02-2009 |
| 20090086901 | X-ray fluorescence visualizing, imaging, or information providing of chemicals, compounds, or biological materials - One aspect can relate to detecting a presence of an at least one chemical, compound, or biological material contained in an at least some matter of an at least a portion of an at least one individual based at least partially on addition of an at least one chemical identifying additive to the at least some matter of the at least the portion of the at least one individual based at least partially on a generation of an at least one induced X-ray fluorescing photon within the at least one chemical identifying additive responsive to a single input energy event in which an at least some input energy is being applied proximal to the at least one chemical, compound, or biological material contained in the at least some matter of the at least the portion of the at least one individual. | 04-02-2009 |
| 20090086902 | Personal transportable X-ray fluorescence visualizing, imaging, or information providing - One aspect relates to inducing at least one induced X-ray fluorescing photon at a X-ray fluorescence event within an at least some matter of an at least a portion of an at least one individual responsive to an at least some input energy being applied to the at least some matter of the at least the portion of the at least one individual. The aspect can relate to detecting the at least one induced X-ray fluorescing photon, wherein the inducing at least one induced X-ray fluorescing photon and the detecting the at least one induced X-ray fluorescing photon is configured to be performed at least partially with at least one device which is configured to be transported portably by a person. | 04-02-2009 |
| 20090086903 | Selective elemental color providing for X-ray fluorescence visualization, imaging, or information providing - One aspect relates to selective X-ray fluorescence visualization, imaging, or information providing of an at least some matter of an at least a portion of an individual that at least partially indicates an at least one differentiatable element composition of the at least some matter of the at least the portion of the individual, wherein the selective X-ray fluorescence visualization, imaging, or information providing selectively displays a first at least one differentiatable element composition of the at least some matter of the at least the portion of the individual at least partially responsive to a first single input energy event based at least partially on an at least some first input energy being applied to the at least some matter of the at least the portion of the individual, and the selective X-ray fluorescence visualization, imaging, or information providing selectively displays a second at least one differentiatable element composition of the at least some matter of the at least the portion of the individual that is interpretable distinctly from the first at least one differentiatable element composition. | 04-02-2009 |
| 20090086904 | X-Ray fluorescence visualizing, imaging, or information providing of chemicals, compounds, or biological materials - One aspect can relate to detecting a prescence of an at least one chemical, compound, or biological material contained in an at least some matter of an at least a portion of an at least one individual based at least partially on addition of an at least one chemical identifying additive to the at least some matter of the at least the portion of the at least one individual based at least partially on a generation of an at least one induced X-ray fluorescing photon within the at least one chemical identifying additive responsive to a single input energy event in which an at least some input energy is being applied proximal to the at least one chemical, compound, or biological material contained in the at least some matter of the at least the portion of the at least one individual. | 04-02-2009 |
| 20090086905 | X-ray fluorescence visualizer, imager, or information provider - One aspect relates to inducing at least one induced X-ray fluorescing photon within an at least some matter of an at least a portion of an at least one individual responsive to a substantial single input energy event based at least partially on an at least some input energy being applied to the at least some matter of the at least the portion of the at least one individual; and detecting the at least one induced X-ray fluorescing photon; and X-ray fluorescence visualizing, imaging, or information providing within the at least some matter of the at least the portion of the at least one individual responsive to the detecting the at least one induced X-ray fluorescing photon. | 04-02-2009 |
| 20090090334 | Opposed piston electromagnetic engine - An engine includes a cylinder having a two pistons slidably disposed therein, a port arranged to admit a reactant into the cylinder between the two pistons, and a converter operable with at least one piston to convert mechanical energy of the piston to electrical energy. | 04-09-2009 |
| 20090091138 | Electromagnetic engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 04-09-2009 |
| 20090091195 | Free piston electromagnetic engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 04-09-2009 |
| 20090094827 | Method of retrofitting an engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 04-16-2009 |
| 20090101153 | Method of facilitated airway intubation - Embodiments include a medical device, an apparatus, and a method. The medical device includes a tube portion shaped and sized for airway passage insertion and having at least one pathway therethrough; and a stylet of at least one shape-transforming material, configured for insertion in one of said at least one pathway; and at least one sensor carried by the tube portion and the stylet. The apparatus includes a stylet having a first end and a second end, at least a portion of the stylet including a shape-transforming material, the stylet being configured for insertion through an airway intubation structure having at least one pathway therethrough; and at least one sensor carried by the stylet in a proximity to the first end. The method includes capturing an image adjacent to an endotracheal tube proximate to an airway passage; and actuating, in response to the image, at least one shape-transformation of the endotracheal tube. | 04-23-2009 |
| 20090101838 | Ionizing-radiation-responsive compositions, methods, and systems - A method, composition and system respond to ionizing radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090101840 | Ionizing-radiation-responsive compositions, methods, and systems - A method composition and system respond to ionizing radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090101841 | Ionizing-radiation-responsive compositions, methods, and systems - A method composition and system respond to ionizing, radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090101846 | Ionizing-radiation-responsive compositions, methods, and systems - A method, composition and system respond to ionizing radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090101875 | Ionizing-radiation-responsive compositions, methods, and systems - A method, composition and system respond to ionizing radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090104113 | Ionizing-radiation-responsive compositions, methods, and systems - A method, composition and system respond to ionizing, radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090104179 | Ionizing-radiation-responsive compositions, methods, and systems - A method, composition and system respond to ionizing radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses. | 04-23-2009 |
| 20090104250 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 04-23-2009 |
| 20090105531 | Disintegrating digestive tract interaction system - Systems and methods are described for configuring several modules each individually small enough to pass through a digestive tract; and a tether or other means for releasably configuring at least the several modules in a group. Such a tether may (directly or indirectly) couple some of the modules via at least a gap in another module from which the tether may slip free, in some embodiments. Such methods may include modes of administering a medication or otherwise taking an action in response to the one or more phenomena. | 04-23-2009 |
| 20090105561 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 04-23-2009 |
| 20090105694 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 04-23-2009 |
| 20090107512 | Condoms configured to facilitate release of nitric oxide - The present disclosure relates to condoms that are configured to facilitate release of nitric oxide. | 04-30-2009 |
| 20090108777 | Devices and systems that deliver nitric oxide - The present disclosure relates to dressings, such as patches and bandages, and other devices and systems that deliver nitric oxide. | 04-30-2009 |
| 20090109803 | Data storage device container - A method of storing a data storage device includes but is not limited to emplacing a data storage device in a container, the container having surfaces; and writing storable data to the data storage device by transmitting energy through a surface of the container. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present application. Other methods and apparatuses are also disclosed. | 04-30-2009 |
| 20090110604 | Substrates for nitric oxide releasing devices - The present disclosure relates to substrates associated with nitric oxide. | 04-30-2009 |
| 20090110612 | Nitric oxide permeable housings - The present disclosure relates to an apparatus that includes one or more nitric oxide permeable housings. | 04-30-2009 |
| 20090110714 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules comprising a first module operable in a digestive or respiratory tract to engage a second module, optionally by a magnetic field. Alternatively or additionally, systems may be operable to remain in situ and also operable to permit a therapeutic material dispensation. In some contexts, for example, systems or methods may dispense a therapeutic material via a subject's throat or elsewhere in the digestive or respiratory tract. | 04-30-2009 |
| 20090110933 | Systems and devices related to nitric oxide releasing materials - The present disclosure relates to systems and devices related to nitric oxide releasing materials. | 04-30-2009 |
| 20090110958 | Systems and devices that utilize photolyzable nitric oxide donors - The present disclosure relates to systems and devices that utilize photolyzable nitric oxide donors. | 04-30-2009 |
| 20090112048 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 04-30-2009 |
| 20090112055 | Sleeves configured to facilitate release of nitric oxide - The present disclosure relates to sleeves that are configured to facilitate release of nitric oxide. | 04-30-2009 |
| 20090112189 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 04-30-2009 |
| 20090112190 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules comprising a first module operable in a digestive or respiratory tract to engage a second module, optionally by a magnetic field. Alternatively or additionally, systems may be operable to remain in situ and also operable to permit a therapeutic material dispensation. In some contexts, for example, systems or methods may dispense a therapeutic material via a subject's throat or elsewhere in the digestive or respiratory tract. | 04-30-2009 |
| 20090112191 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules comprising a first module operable in a digestive or respiratory tract to engage a second module, optionally by a magnetic field. Alternatively or additionally, systems may be operable to remain in situ and also operable to permit a therapeutic material dispensation. In some contexts, for example, systems or methods may dispense a therapeutic material via a subject's throat or elsewhere in the digestive or respiratory tract. | 04-30-2009 |
| 20090112193 | Systems and devices that utilize photolyzable nitric oxide donors - The present disclosure relates to systems and devices that utilize photolyzable nitric oxide donors. | 04-30-2009 |
| 20090112197 | Devices configured to facilitate release of nitric oxide - The present disclosure relates to devices that facilitate release of nitric oxide from one or more photolyzable nitric oxide donors. | 04-30-2009 |
| 20090112243 | Surgical cutter with dispensing system for tissue sealants - The present invention discloses a medical device comprising a dispenser adapted to dispense a tissue sealant or one or more precursor compounds, the dispenser being operably coupled to a surgical stapler, which in turn is configured to deliver one or more surgical staples or fasteners in an area of bodily tissue approximation surface. Furthermore, the medical device comprises a dispenser adapted to dispense a tissue sealant or one or more precursor compounds thereof, the dispenser being operably coupled to a surgical cutter. Additionally or alternatively the medical; device can include an actuation mechanism, whereby the dispenser dispenses the tissue sealant or one or more precursor compounds at a surgical cutting site or in a proximity thereof. | 04-30-2009 |
| 20090112256 | Suturing device with tissue sealant dispenser - The present invention discloses a medical device comprising a dispenser adapted to dispense a tissue sealant or one or more precursor compounds, the dispenser being operably coupled to a surgical suturing device, which in turn is configured to deliver one or more surgical sutures or fasteners in an area of bodily tissue approximation surface. Furthermore, the medical device comprises a dispenser adapted to dispense a tissue sealant or one or more precursor compounds thereof, the dispenser being operably coupled to a surgical cutter. Additionally or alternatively the medical; device can include a microactuation mechanism, whereby the dispenser dispenses the tissue sealant or one or more precursor compounds at a surgical cutting site or in a proximity thereof. | 04-30-2009 |
| 20090112295 | Devices and systems that deliver nitric oxide - The present disclosure relates to dressings, such as patches and bandages, and other devices and systems that deliver nitric oxide. | 04-30-2009 |
| 20090112485 | Nitric oxide sensors and systems - The present disclosure relates to nitric oxide sensors and systems. | 04-30-2009 |
| 20090117001 | Event-triggered ultraviolet light sterilization of surfaces - Solutions for limiting the undesirable spread of pathogens by indirect contact are provided. The solutions involve event-controlled self-sterilization of contact regions on articles or fixtures. A self-sterilizing article structure, in response to a contact event, allows sterilizing UV energy to controllably flow from a UV generator within the article to a portion of the contact region. | 05-07-2009 |
| 20090124049 | Deletable nanotube circuit - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 05-14-2009 |
| 20090130017 | Targeted short-lived drug delivery - An aspect of the disclosure includes a system for delivering therapeutic agents. In an embodiment, the system includes an implantable medical device comprising at least one reservoir that holds at least one therapeutic agent. Additionally the device includes a delivery mechanism that provides non-systemic in vivo delivery of the at least one therapeutic agent to a local area of an animal in a therapeutically-effective concentration, wherein the therapeutically-effective concentration is in excess of a concentration that would produce a toxic effect when administered systemically to the animal. Furthermore, the at least one therapeutic agent has short half-life. A further aspect of the disclosure includes a method of delivering a therapeutic agent in vivo at non-systemic high doses to a localized area of an animal. | 05-21-2009 |
| 20090131737 | Lumen-traveling biological interface device and method of use - Lumen-traveling biological interface devices and associated methods and systems are described. Lumen-traveling biological interface devices capable of traveling within a body lumen may include a propelling mechanism to produce movement of the lumen-traveling device within the lumen, electrodes or other electromagnetic transducers for detecting biological signals and electrodes, coils or other electromagnetic transducers for delivering electromagnetic stimuli to stimulus responsive tissues. Lumen-traveling biological interface devices may also include additional components such as sensors, an active portion, and/or control circuitry. | 05-21-2009 |
| 20090131738 | Lumen-traveling biological interface device and method of use - Lumen-traveling biological interface devices and associated methods and systems are described. Lumen-traveling biological interface devices capable of traveling within a body lumen may include a propelling mechanism to produce movement of the lumen-traveling device within the lumen, electrodes or other electromagnetic transducers for detecting biological signals and electrodes, coils or other electromagnetic transducers for delivering electromagnetic stimuli to stimulus responsive tissues. Lumen-traveling biological interface devices may also include additional components such as sensors, an active portion, and/or control circuitry. | 05-21-2009 |
| 20090136099 | Image guided surgery with dynamic image reconstruction - A method may include processing two or more fiducials included in a three-dimensional medical image and included in a current image to generate two or more transform coefficients of a transform, and applying the transform to the three-dimensional medical image to form a present image. | 05-28-2009 |
| 20090137866 | Medical or veterinary digestive tract utilization systems and methods - Systems and methods are described for implementing or deploying medical or veterinary utility modules (a) operable for mooring at least partly within a digestive tract, (b) small enough to pass through the tract per vias naturales and including a wireless-control component, (c) having one or more attachment protrusions positionable adjacent to a mucous membrane, (d) configured to facilitate redundant modes of attachment, (e) facilitating a “primary” material supply deployable within a stomach for an extended and/or controllable period, (f) moored by one or more adaptable extender modules supported by a subject's head or neck, and/or (g) configured to facilitate supporting at least a sensor within a subject's body lumen for up to a day or more. | 05-28-2009 |
| 20090142413 | Targeted short-lived drug delivery - An aspect of the disclosure includes a system for delivering therapeutic agents. In an embodiment, the system includes an implantable medical device comprising at least one reservoir that holds at least one therapeutic agent. Additionally the device includes a delivery mechanism that provides non-systemic in vivo delivery of the at least one therapeutic agent to a local area of an animal in a therapeutically-effective concentration, wherein the therapeutically-effective concentration is in excess of a concentration that would produce a toxic effect when administered systemically to the animal. Furthermore, the at least one therapeutic agent has short half-life. A further aspect of the disclosure includes a method of delivering a therapeutic agent in vivo at non-systemic high doses to a localized area of an animal. | 06-04-2009 |
| 20090142415 | Selective resonance of chemical structures - Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs. | 06-04-2009 |
| 20090143816 | Grasper with surgical sealant dispenser - The present disclosure is directed to a medical device comprising a dispenser adapted to dispense a tissue sealant or one or more precursor compounds, the dispenser being operably coupled to a grasper. Furthermore, the medical device comprises a dispenser adapted to dispense a tissue sealant or one or more precursor compounds thereof, the dispenser being operably coupled to a surgical cutter. Additionally or alternatively the medical device can include an actuation mechanism, whereby the dispenser dispenses the tissue sealant or one or more precursor compounds at a surgical cutting site or in a proximity thereof. | 06-04-2009 |
| 20090149693 | Method for magnetic modulation of neural conduction - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with magnetic stimuli are disclosed. Methods and systems for reversing effects of blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149694 | System for magnetic modulation of neural conduction - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with magnetic stimuli are disclosed. Methods and systems for reversing effects of blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149708 | Treatment techniques using ingestible device - An apparatus, device, methods, computer program product, and systems are described that determine a control command at a patient internal device within a patient, and provide the control command to an ingestible device within the patient, the control command including instructions to the ingestible device to control an operation thereof. | 06-11-2009 |
| 20090149797 | System for reversible chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149798 | Implant system for chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Implantable systems for delivery of chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149799 | Method for chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149839 | Treatment techniques using ingestible device - An apparatus, device, methods, computer program product, and systems are described that determine a control command at a patient internal device within a patient, and provide the control command to an ingestible device within the patient, the control command including instructions to the ingestible device to control an operation thereof. | 06-11-2009 |
| 20090149895 | Method and system for cyclical neural modulation based on activity state - Methods and related systems for modulating neural activity by repetitively or cyclically blocking conduction in a peripheral neural structure are disclosed. Timing of delivery of blocking stimuli may be based upon overall activity level of the subject or use/activity of a portion of the body of a subject. | 06-11-2009 |
| 20090149896 | System for chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149897 | System for transdermal chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Systems for transdermal delivery of chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149911 | System for electrical modulation of neural conduction - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with electrical stimuli are disclosed. Methods and systems for reversing effects of blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149912 | Method for electrical modulation of neural conduction - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with electrical stimuli are disclosed. Methods and systems for reversing effects of blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149914 | Method for reversible chemical modulation of neural activity - Methods and related systems for modulating neural activity by repetitively blocking conduction in peripheral neural structures with chemical blocking agents are disclosed. Methods and systems for reversing effects of chemical blocking agents and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149919 | Method for thermal modulation of neural activity - Methods and related systems for modulating neural activity by blocking conduction in peripheral neural structures with thermal stimuli are disclosed. Methods and systems for reversing effects of thermal blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090149926 | System for thermal modulation of neural activity - Methods and related systems for modulating neural activity by blocking conduction in peripheral neural structures with thermal stimuli are disclosed. Methods and systems for reversing effects of thermal blocking stimuli and/or for producing substantially permanent conduction block are also disclosed. | 06-11-2009 |
| 20090150089 | Selective resonance of chemical structures - Chemical compositions may be selectively or preferentially excited by the application of scores comprising a series of energy inputs. | 06-11-2009 |
| 20090156988 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157054 | Treatment indications informed by a priori implant information - Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157055 | Treatment indications informed by a priori implant information - Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants: or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lactic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157056 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157057 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157058 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. Some involve implementing or deploying therapeutic administration systems, for example, for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lytic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090157059 | Surgical instrument navigation system - The disclosure pertains to a surgical system. In an embodiment, the system comprises one or more sensors operably responsive to physical boundary limitations of an operating field. Furthermore, the one or more sensors provide information regarding the physical boundary limitations of the operating field. In another embodiment, the system comprises a surgical instrument that is configured to respond to the information by either activation or inactivation. In another aspect the disclosure includes generating an anatomical image or anatomic positional reference data from one or more anatomical objects. Additionally, the method includes creating haptic feedback signals based at least partly on the anatomical image or anatomic positional reference data, and determining a position or orientation of a surgical instrument. Furthermore the method includes activating or inactivating the surgical instrument based at least partly on the haptic feedback signals. | 06-18-2009 |
| 20090157171 | Treatment indications informed by a priori implant information - Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a priori implant information and signaling a decision whether to initiate implant-site-targeting treatment partly based on the a priori implant information and partly based on one or more other clot-indicative determinants; or obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement; or obtaining one or more indications of a lactic material in a vicinity of one or more body lumens and accelerating a decrease in a local concentration of the lytic material in the vicinity of the one or more body lumens by causing one or more elements to extract at least a portion of the lytic material in the vicinity of the one or more body lumens in response to the one or more indications of the lytic material in the vicinity of the one or more body lumens; or one or more capture components configured to accelerate a decrease in a local concentration of one or more therapeutic structures along a downstream portion of a vasculature and one or more dispensation components configured to release the one or more therapeutic structures into an upstream portion of the vasculature. | 06-18-2009 |
| 20090162249 | Acoustically controlled reaction device - Embodiments of a system including a remotely controlled reaction device and associated controller are described. Methods of use and control of the device are also disclosed. According to various embodiments, a reaction device is placed in an environment in order to perform a chemical reaction in an environment. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. In selected embodiments, an acoustic control signal may be used. | 06-25-2009 |
| 20090162250 | Acoustically controlled reaction device - Embodiments of a system including a remotely controlled reaction device and associated controller are described. Methods of use and control of the device are also disclosed. According to various embodiments, a reaction device is placed in an environment in order to perform a chemical reaction in an environment. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. In selected embodiments, an acoustic control signal may be used. | 06-25-2009 |
| 20090166103 | Limbed vehicles, systems and methods using same, and post networks on which limbed vehicles travel - Embodiments disclosed herein relate to systems including a limbed vehicle having a plurality of controllably movable limbs (e.g., a limbed machine, limbed robot, etc.), a plurality of spaced posts that the limbed vehicle may travel on using the limbs, and at least one logistical-support unit associated with at least one of the posts and configured to provide logistical support to the limbed vehicle. As non-limiting examples, such disclosed embodiments of systems may be used to service an agriculture field, to enable travel over an environmentally-sensitive area or an area impassable by a conventional wheeled or tracked vehicle, and may be used in many other different applications. Embodiments disclosed herein also relate to limbed vehicles configured to receive logistical support from a logistical-support unit, methods of providing logistical support to such limbed vehicles, post networks, and posts. | 07-02-2009 |
| 20090166104 | Systems and methods employing limbed vehicle and spaced posts - Embodiments disclosed herein relate to systems including a limbed vehicle having a plurality of controllably movable limbs (e.g., a limbed machine, limbed robot, etc.) and a plurality of spaced posts that the limbed vehicle may travel on using the limbs. As non-limiting examples, such disclosed embodiments of systems may be used to service an agriculture field, to enable travel over an environmentally-sensitive area or an area impassable by a conventional wheeled or tracked vehicle, and may be used in many other different applications. Embodiments disclosed herein also relate to methods of operating a limbed vehicle to travel on a plurality of spaced posts. | 07-02-2009 |
| 20090166105 | Limbed vehicles, systems and methods using same, and post networks on which limbed vehicles travel - Embodiments disclosed herein relate to systems including a limbed vehicle having a plurality of controllably movable limbs (e.g., a limbed machine, limbed robot, etc.) and a plurality of spaced posts that the limbed vehicle may travel on using the controllably movable limbs. As non-limiting examples, such disclosed embodiments of systems may be used to service an agriculture field, to enable travel over an environmentally-sensitive area or an area impassable by a conventional wheeled or tracked vehicle, and may be used in many other different applications. Embodiments disclosed herein also relate to methods of operating a limbed vehicle to travel on a plurality of spaced posts, limbed vehicles, post networks, and posts. | 07-02-2009 |
| 20090171263 | System, devices, and methods including actively-controllable superoxide water generating systems - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 07-02-2009 |
| 20090171547 | Traffic-sensitive engine control - A method and engine control system for controlling a vehicle, including determining an acceptable range for an engine operating parameter responsive to traffic conditions and directing the engine to maintain the engine operating parameter within the acceptable range. | 07-02-2009 |
| 20090171548 | System and method for operating a vehicle - A method of operating a vehicle including, during operation of the engine, receiving a control signal broadcast from outside the vehicle including instructions for modifying a vehicle operating parameter and modifying the vehicle operating parameter in accordance with the instructions. | 07-02-2009 |
| 20090171549 | Condition-sensitive exhaust control - A method and exhaust control system for controlling a vehicle, including adjusting a vehicle parameter in response to a determined ambient condition or to local time. | 07-02-2009 |
| 20090171555 | System and method for remotely modifying vehicle operations - A method and control system for controlling an engine in a vehicle includes broadcasting a control signal including instructions for modification of a vehicle parameter to the vehicle during operation of the engine. | 07-02-2009 |
| 20090173386 | Water alteration structure applications and methods - A method is generally described which includes environmental alteration. The method includes determining a placement of at least one vessel capable of moving water to lower depths in the water via wave induced downwelling. The method also includes placing the at least one vessel in the determined placement. Further, the method includes generating movement of the water adjacent the surface of the water in response to the placing. | 07-09-2009 |
| 20090173404 | Water alteration structure and system - A system is described generally for providing a structure or structures for altering water surface temperature. The system includes a holding vessel configured to hold water. The holding vessel has at least one wall coupled to a lowermost portion. The at least one wall extends above the water level and the lowermost portion is configured to be submerged. At least one conduit extends from the lower side of the holding vessel. The at least one conduit has a length extending to a depth at which a property of water at the depth is substantially different from that of the water at the surface. | 07-09-2009 |
| 20090173801 | Water alteration structure and system having below surface valves or wave reflectors - A system is described generally for providing a structure or structures for altering water surface temperature. The system includes a holding vessel configured to hold water. The holding vessel has at least one wall coupled to a lowermost portion. The at least one wall extends above the water level and the lowermost portion is configured to be submerged. At least one conduit extends from the lower side of the holding vessel. The at least one conduit has a length extending to a depth at which a property of water at the depth is substantially different from that of the water at the surface. The at least one conduit or the holding vessel includes at least one aperture formed in at least one of the holding vessel or the at least one conduit and located at a distance below the mean surface water level and at least one one way valve is coupled to the at least one aperture and allowing flow of water in only one direction. | 07-09-2009 |
| 20090175402 | Method and system for providing fuel in a nuclear reactor - Exemplary embodiments provide automated nuclear fission reactors and methods for their operation. Exemplary embodiments and aspects include, without limitation, re-use of nuclear fission fuel, alternate fuels and fuel geometries, modular fuel cores, fast fluid cooling, variable burn-up, programmable nuclear thermostats, fast flux irradiation, temperature-driven surface area/volume ratio neutron absorption, low coolant temperature cores, refueling, and the like. | 07-09-2009 |
| 20090175685 | Water alteration structure movement method and system - A structure described generally for altering one or more properties within a body of water includes a vessel configured to hold water. The vessel may have at least one wall. The at least one wall extends at least above a mean surface water level. At least one conduit extends downward from the holding vessel. The at least one conduit has a length that extends below the surface of the water. A propulsion system may be coupled to at least one of the vessel or the conduit and may be configured to provide forces to the vessel. | 07-09-2009 |
| 20090177139 | System, devices, and methods including actively-controllable electromagnetic energy-emitting delivery systems and energy-activateable disinfecting agents - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 07-09-2009 |
| 20090177254 | System, devices, and methods including actively-controllable electrostatic and electromagnetic sterilizing excitation delivery system - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 07-09-2009 |
| 20090177569 | Water alteration structure risk management or ecological alteration management systems and methods - A method of managing risk includes selling individual insurance policies regarding areas to be protected by storm suppression equipment. The method discussed also includes finding at least one of purchase, operation, or maintenance of the storm suppression equipment at least partially through premiums collected from the selling. | 07-09-2009 |
| 20090192449 | Adaptive dispensation in a digestive tract - Systems and methods are described for implementing a bioactive material selection from within a digestive tract and transmitting a wireless signal indicating at least the bioactive material selection from within the digestive tract. | 07-30-2009 |
| 20090195751 | Vision modification with reflected image - Various embodiments of methods and systems for improving and enhancing vision are disclosed. Adjustable lenses or optical systems may be used to provide adaptive vision modification. In some embodiments, vision modification may be responsive to the current state of the user's visual system. Certain embodiments provide correction of the subject's near and far vision. Other embodiments provide enhancement of vision beyond the physiological ranges of focal length or magnification. | 08-06-2009 |
| 20090231099 | Method and apparatus for tracking plants with electronic tag - One or more plants may be associated with an electronic tag including a memory circuit and interrogation interface. The memory circuit in the electronic tag may include data corresponding to the one or more plants. According to an embodiment the data may include plant care information such as a record of treatments received by the one or more plants and/or plant care instructions. The data may be structured. | 09-17-2009 |
| 20090231101 | Electronic tag and method for using an electronic tag configured to track at least one plant - A system for tracking at least one plant includes an electronic tag including an interrogation interface and memory circuitry and a package for the electronic tag, the package being configured for physical association with at least one corresponding plant. The package may be configured for self-contained physical association with the at least one plant. The electronic tag may be interrogated by multiple trading partners in a supply chain. | 09-17-2009 |
| 20090231102 | Electronic tag configured to sense a plant environment - A system for tracking at least one plant includes an electronic tag including an interrogation interface and memory circuitry and a package for the electronic tag, the package being configured for physical association with at least one corresponding plant. | 09-17-2009 |
| 20090231110 | Method and system for correlating external data to a plant with an electronic tag - One or more plants may be associated with an electronic tag including a memory circuit and interrogation interface. The memory circuit in the electronic tag may include data corresponding to the one or more plants. According to an embodiment the data may include at least one data coordinate corresponding to an external database holding data related to the one or more plants. The external database may hold plant care information such as a record of treatments received by the one or more plants and/or plant care instructions, for example. The data may be structured. | 09-17-2009 |
| 20090232268 | System and method for operating a modular nuclear fission deflagration wave reactor - Illustrative embodiments provide modular nuclear fission deflagration wave reactors and methods for their operation. Illustrative embodiments and aspects include, without limitation, modular nuclear fission deflagration wave reactors, modular nuclear fission deflagration wave reactor modules, methods of operating a modular nuclear fission deflagration wave reactor, and the like. | 09-17-2009 |
| 20090237212 | Electronic tag and system with conditional response corresponding to at least one plant attribute - A system for tracking plants includes electronic tags configured to conditionally respond to interrogation, the condition response corresponding to data stored in the tag and/or one or more environmental parameters corresponding to one or more plants. | 09-24-2009 |
| 20090243832 | Electronic tag with indicator - An electronic tag may include a human perceptible indicator configured to indicate a need for one or more treatments by at least one corresponding plant. | 10-01-2009 |
| 20090252273 | Automated nuclear power reactor for long-term operation - Exemplary embodiments provide automated nuclear fission reactors and methods for their operation. Exemplary embodiments and aspects include, without limitation, re-use of nuclear fission fuel, alternate fuels and fuel geometries, modular fuel cores, fast fluid cooling, variable burn-up, programmable nuclear thermostats, fast flux irradiation, temperature-driven surface area/volume ratio neutron absorption, low coolant temperature cores, refueling, and the like. | 10-08-2009 |
| 20090252283 | Nuclear fission reactor fuel assembly adapted to permit expansion of the nuclear fuel contained therein - A nuclear fission reactor fuel assembly adapted to permit expansion of the nuclear fuel contained therein. The fuel assembly comprises an enclosure having enclosure walls to sealingly enclose a nuclear fuel foam defining a plurality of interconnected open-cell voids or a plurality of closed-cell voids. The voids permit expansion of the foam toward the voids, which expansion may be due to heat generation and/or fission gas release. The voids shrink or reduce in volume as the foam expands. Pressure on the enclosure walls is substantially reduced because the foam expands toward and even into the voids rather than against the enclosure walls. Thus, the voids provide space into which the foam can expand. | 10-08-2009 |
| 20090259112 | Sensors - The present disclosure relates to sensors and systems associated with the sensors. | 10-15-2009 |
| 20090259214 | Agent delivery device - The present disclosure relates to agent delivery devices and related systems. | 10-15-2009 |
| 20090259215 | Methods and systems associated with delivery of one or more agents to an individual - The present disclosure relates to methods and systems for administration of one or more agents. | 10-15-2009 |
| 20090259217 | Methods and systems associated with delivery of one or more agents to an individual - The present disclosure relates to methods and systems for administration of one or more agents. | 10-15-2009 |
| 20090261959 | Energy dissipative cushioning system - An apparatus, method, computer program product, and/or system are described that determine a pre-collision event, actuate, in response to determining the pre-collision event, a cushioning element prior to a collision between a first object and a second object, the cushioning element including one or more tension-bearing members to dissipate at least some of an energy associated with the collision based on deforming at least one of the tension-bearing members during the collision, determine an updated status of the collision, and adjust one or more properties of the cushioning element based on the updated status of the collision. Other example embodiments are also provided relating to energy dissipative cushioning systems. | 10-22-2009 |
| 20090267758 | Systems and apparatus for measuring a bioactive agent effect - Apparatus and systems are described that include physical media related to accepting at least one attribute associated with an individual from a licensed health care provider and/or presenting an output of an artificial sensory experience associated with a request to measure at least one effect of a bioactive agent on the attribute associated with individual. | 10-29-2009 |
| 20090269329 | Combination Therapeutic products and systems - Combination therapeutics, computer program products, and systems are described that include at least one combined prescription psychiatric medication and at least one artificial sensory experience for treating a psychiatric disorder | 10-29-2009 |
| 20090270687 | Methods and systems for modifying bioactive agent use - Methods, computer program products, and systems are described that include measuring at least one effect of a combined bioactive agent and artificial sensory experience on an individual and/or modifying at least one of the bioactive agent or the artificial sensory experience at least partially based on the at least one effect. | 10-29-2009 |
| 20090270688 | Methods and systems for presenting a combination treatment - Methods, computer program products, and systems are described that include accepting an indication of an individual's compliance with an artificial sensory experience and presenting an indication of a bioactive agent at least partly based on the indication of the individual's compliance with the artificial sensory experience. | 10-29-2009 |
| 20090270692 | Combination treatment alteration methods and systems - Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent. | 10-29-2009 |
| 20090270693 | Methods and systems for modifying bioactive agent use - Methods, computer program products, and systems are described that include measuring at least one effect of a combined bioactive agent and artificial sensory experience on an individual and/or modifying at least one of the bioactive agent or the artificial sensory experience at least partially based on the at least one effect. | 10-29-2009 |
| 20090270694 | Methods and systems for monitoring and modifying a combination treatment - Methods, computer program products, and systems are described that include monitoring at least one health attribute of an individual during an artificial sensory experience, associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual, and/or modifying at least one of a bioactive agent or the artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual. | 10-29-2009 |
| 20090270786 | Methods and systems for presenting a combination treatment - Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual. | 10-29-2009 |
| 20090271008 | Combination treatment modification methods and systems - Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or modifying an artificial sensory experience to alter at least one effect of the bioactive agent. | 10-29-2009 |
| 20090271009 | Combination treatment modification methods and systems - Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or modifying an artificial sensory experience to alter at least one effect of the bioactive agent. | 10-29-2009 |
| 20090271010 | Combination treatment alteration methods and systems - Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent. | 10-29-2009 |
| 20090271011 | Methods and systems for monitoring bioactive agent use - Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one desired effect of the bioactive agent on the individual. | 10-29-2009 |
| 20090271120 | Methods and systems for monitoring bioactive agent use - Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one desired effect of the bioactive agent on the individual. | 10-29-2009 |
| 20090271121 | Methods and systems for detecting a bioactive agent effect - Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent. | 10-29-2009 |
| 20090271122 | Methods and systems for monitoring and modifying a combination treatment - Methods, computer program products, and systems are described that include monitoring at least one attribute of an individual during an artificial sensory experience while the individual is under the influence of a bioactive agent, identifying at least one characteristic of the artificial sensory experience that is proximate to a desired change in the at least one attribute of the individual, and/or modifying at least one of the artificial sensory experience or the bioactive agent at least partly based on the identifying at least one characteristic of the artificial sensory experience that is proximate to the desired change in the at least one attribute of the individual. | 10-29-2009 |
| 20090271213 | Combination treatment selection methods and systems - Methods, computer program products, and systems are described that include accepting at least one attribute of at least one individual, querying at least one database at least partly based on the at least one attribute, selecting from the at least one database at least one prescription medication and at least one artificial sensory experience to address the at least one attribute of at least one individual, and/or presenting an indication of the at least one prescription medication and the at least one artificial sensory experience at least partly based on the selecting from the at least one database at least one prescription medication and at least one artificial sensory experience to address the at least one attribute of at least one individual | 10-29-2009 |
| 20090271215 | Methods and systems for detecting a bioactive agent effect - Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent. | 10-29-2009 |
| 20090271217 | Side effect ameliorating combination therapeutic products and systems - Combination therapeutics, computer program products, and systems are described that include at least one combined prescription psychiatric medication and at least one artificial sensory experience for ameliorating at least one side effect of the psychiatric medication. | 10-29-2009 |
| 20090271219 | Methods and systems for presenting a combination treatment - Methods, computer program products, and systems are described that include accepting an indication of an individual's compliance with an artificial sensory experience and presenting an indication of a bioactive agent at least partly based on the indication of the individual's compliance with the artificial sensory experience. | 10-29-2009 |
| 20090271347 | Methods and systems for monitoring bioactive agent use - Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual. | 10-29-2009 |
| 20090271375 | Combination treatment selection methods and systems - Methods, computer program products, and systems are described that include accepting at least one attribute of at least one individual, querying at least one database at least partly based on the at least one attribute, selecting from the at least one database at least one prescription medication and at least one artificial sensory experience to address the at least one attribute of at least one individual, and/or presenting an indication of the at least one prescription medication and the at least one artificial sensory experience at least partly based on the selecting from the at least one database at least one prescription medication and at least one artificial sensory experience to address the at least one attribute of at least one individual | 10-29-2009 |
| 20090276011 | Intrusion resistant implantable medical device - Provided embodiments include a device, apparatus, system, computer program product, and method. A medical apparatus is provided. At least a portion of which is configured for implantation in an animal. The medical apparatus includes a communication module configured to receive communications originating external to the animal. The medical apparatus also includes a threat assessment module configured to ascertain a threat characteristic of a communication received by the communication module. The medical apparatus further includes a threat mitigation module configured to implement a mitigation measure responsive to the ascertained threat characteristic of the received communication. | 11-05-2009 |
| 20090276012 | Secure operation of implanted device - Provided embodiments include a device, apparatus, system, computer program product, and method. A provided method includes a method implemented in a medical apparatus implanted in an animal and configured to at least one of transmit or receive a communication externally of the animal. The method includes receiving a communication. The method also includes detecting an indication of a malware in the received communication. The method further includes implementing in the implanted medical device a countermeasure responsive to the detected indication of malware in the received communication. | 11-05-2009 |
| 20090283534 | Storage container including multi-layer insulation composite material having bandgap material and related methods - In one embodiment, a storage container includes a container structure defining at least one storage chamber. The container structure includes multi-layer insulation (MLI) composite material having at least one thermally-reflective layer. The at least one thermally-reflective layer includes bandgap material that is transmissive to radio-frequency electromagnetic radiation. | 11-19-2009 |
| 20090284378 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090285348 | Heat pipe fission fuel element - Illustrative embodiments provide nuclear fission fuel elements, and systems, applications, apparatuses, and methods related thereto. Illustrative embodiments and aspects include, without limitation, nuclear fission fuel elements, heat pipe assemblies, heat pipes, methods of fabricating a nuclear fission fuel element, methods of fabricating a heat pipe assembly, and the like. | 11-19-2009 |
| 20090285349 | Heat pipe fission fuel element - Illustrative embodiments provide nuclear fission fuel elements, and systems, applications, apparatuses, and methods related thereto. Illustrative embodiments and aspects include, without limitation, nuclear fission fuel elements, heat pipe assemblies, heat pipes, methods of fabricating a nuclear fission fuel element, methods of fabricating a heat pipe assembly, and the like. | 11-19-2009 |
| 20090286022 | Multi-layer insulation composite material including bandgap material, storage container using same, and related methods - In one embodiment, a multi-layer insulation (MLI) composite material includes a first thermally-reflective layer and a second thermally-reflective layer spaced from the first thermally-reflective layer. At least one of the first or second thermally-reflective layers includes bandgap material that is reflective to infrared electromagnetic radiation. A region between the first and second thermally-reflective layers impedes heat conduction between the first and second thermally-reflective layers. Other embodiments include a storage container including a container structure that may be at least partially formed from such MLI composite materials, and methods of using such MLI composite materials. | 11-19-2009 |
| 20090287093 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287094 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287101 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287109 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287110 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287120 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090287191 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-19-2009 |
| 20090292212 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-26-2009 |
| 20090292213 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-26-2009 |
| 20090292214 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-26-2009 |
| 20090292222 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 11-26-2009 |
| 20090296887 | Aspects of compton scattered X-RAY visualization, imaging, or information providing - One aspect relates to visualizing, imaging, or providing information at least partially through at least some matter of an at least a portion of an individual, based at least in part on Compton scattering to at least partially form scattered X-rays, the Compton scattering occurring primarily in the at least some matter of the at least the portion of the individual, wherein the visualizing, imaging, or providing information is at least partially performed by converting the scattered X-rays into an at least one scintillated viewable and/or visible light that is detectable by a user. Another aspect relates to Compton scattered X-ray based visualizing, imaging, or providing information of an at least some matter of an at least a portion of an at least one individual to allow the at least one individual and/or an untrained assistant to at least partially visualize, image, or provide information into the at least some matter of the at least the portion of the individual based at least partially on Compton scattered X-rays. | 12-03-2009 |
| 20090297098 | PHOTONIC BAND GAP ROUTER - An arrangement includes a photonic band-gap assembly comprising at least one input wave guide and at least one output wave guides, and at least one routing element responsive to signals to selectively route a signal from the input wave guide to one or more of the output wave guides. | 12-03-2009 |
| 20090311269 | Methods for collecting and detecting oligonucleotides - Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal. | 12-17-2009 |
| 20090311270 | Methods, compositions, and kits for collecting and detecting oligonucleotides - Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal. | 12-17-2009 |
| 20090311665 | Methods, compositions, and kits for collecting and detecting oligonucleotides - Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal. | 12-17-2009 |
| 20090319301 | Methods and systems for presenting a combination treatment - Methods, computer program products, and systems are described that include accepting an indication of a schedule for administration of a bioactive agent to an individual and presenting an indication of an artificial sensory experience at least partly based on the accepting an indication of the schedule for administration of the bioactive agent to the individual. | 12-24-2009 |
| 20090321427 | Microwave Oven - Generally and not exclusively, a microwave cooking oven to cook food in a microwave chamber includes at least one array of radiation detectors. An exemplary method includes sensing an optical depth of the item along each of multiple beam paths from at least two sides of the item, and mapping isothermal regions in the interior of the item 3-dimensionally based on the sensing. Another exemplary method includes sensing a microwave power representing a value of a heatability property for each of multiple regions of the same item, and applying a different measure of the microwave power to each of the different regions according to the value of the heatability property in each individual region. Yet another exemplary method includes sensing different frequencies of the microwave power in the microwave chamber, and changing the frequency of the microwave power for heating the item, as the item undergoes heating. | 12-31-2009 |
| 20090321428 | Microwave oven - Generally and not exclusively, a microwave cooking oven to cook food in a microwave chamber (e.g., a cooking chamber) includes a microwave power source, and a microwave control unit. In one implementation, the control unit includes an array of radiation detectors to detect the microwave power of multiple microwave beams in the cooking chamber, a modeler to map the temperature in different regions of an item in the microwave chamber, and a controller to adjust microwave power being delivered to each region of the item. In one implementation, the control unit can detect the presence and food type of an item in the microwave chamber. The control unit can provide a real time heating and cooking status of each region of an item being heated in the microwave chamber. | 12-31-2009 |
| 20090321429 | Microwave oven - Generally and not exclusively, a microwave cooking oven to cook food in a microwave chamber (e.g., a cooking chamber) includes a microwave power source, and a microwave control unit. The control unit includes a microwave detector to detect the microwave power in the cooking chamber, and a control circuit to determine the food optical density or food temperature, based on the microwave power being absorbed by the food. The control circuit determines the microwave power being absorbed based on the difference between the power emitted into the cooking chamber and the power detected within the cooking chamber. In one illustrative embodiment, microwave power is emitted by multiple ports from different directions, and the microwave power absorbed by the food along these different directions is measured. The control circuit then determines the optical density or temperature of the food along each direction. In one illustrative embodiment, the control circuit directs the power source to emit microwave power based on the determined power being absorbed by the food. | 12-31-2009 |
| 20090326443 | Preparatory dispensation systems and methods - Methods and systems are described for receiving wireless control signal content into a module containing one or more active ingredients and causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module; or for obtaining data indicating a future event time intended by an individual, and causing a bioactive material administration to the individual in response to the data to occur about or before the future event time. | 12-31-2009 |
| 20090326516 | Preparatory dispensation systems and methods - Methods and systems are described for receiving wireless control signal content into a module containing one or more active ingredients and causing one or more dispensations from the module according to a programmatic dispensation profile partly dependent on the wireless control signal content and partly dependent on an attribute of the module; or for obtaining data indicating a future event time intended by an individual, and causing a bioactive material administration to the individual in response to the data to occur about or before the future event time. | 12-31-2009 |
| 20100004567 | Wearable/portable protection for a body - In one embodiment, a particular state of a body is sensed. In response to the sensing, at least one action is taken to modulate a projected adverse interaction between the body or a portion thereof and at least one object in the environment of the body. | 01-07-2010 |
| 20100008819 | Event-triggered self-sterilization of article surfaces - Solutions for limiting the undesirable spread of pathogens by indirect contact are provided. The solutions involve event-controlled self-sterilization of contact surfaces on articles or fixtures. A self-sterilizing contact surface structure allows chemical sterilizing agents to controllably flow in response to a contact event, from within the article to exude upon a portion of the contact surface. | 01-14-2010 |
| 20100008822 | Event-triggered self-sterilization of article surfaces - Solutions for limiting the undesirable spread of pathogens by indirect contact are provided. The solutions involve event-controlled self-sterilization of contact surfaces on articles or fixtures. A self-sterilizing contact surface structure allows chemical sterilizing agents to controllably flow in response to a contact event, from within the article to exude upon a portion of the contact surface. | 01-14-2010 |
| 20100018981 | Multi-layer insulation composite material having at least one thermally-reflective layer with through openings, storage container using the same, and related methods - In an embodiment, a multi-layer insulation (MLI) composite material includes a first thermally-reflective layer and a second thermally-reflective layer spaced from the first thermally-reflective layer. At least one of the first or second thermally-reflective layers includes a plurality of through openings configured to at least partially obstruct transmission therethrough of infrared electromagnetic radiation having a wavelength greater than a threshold wavelength. A region between the first and second thermally-reflective layers impedes heat conduction between the first and second thermally-reflective layers. Other embodiments include a storage container including a container structure that may be at least partially formed from such MLI composite materials, and methods of using such MLI composite materials. | 01-28-2010 |
| 20100022487 | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject - A method, device, or kit is provided which maintain a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on pre-menopausal cyclic steroid hormone levels of the subject and on current cyclic steroid hormone levels of the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological cyclic pre-menopausal levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100022488 | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject - A method, device, or kit is provided which maintain a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on pre-menopausal cyclic steroid hormone levels of the subject and on current cyclic steroid hormone levels of the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological cyclic pre-menopausal levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100022489 | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject - A method, device, or kit is provided which maintain a substantially physiological level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on steroid hormone levels prior to disease diagnosis in the subject and on current steroid hormone levels in the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological pre-disease levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100022494 | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject - A method, device, or kit is provided which maintain a substantially physiological level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on steroid hormone levels prior to disease diagnosis in the subject and on current steroid hormone levels in the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological pre-disease levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100022497 | Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject - A method for treating cardiovascular disease in a mammalian subject includes providing to the subject at least one treatment regimen including at least one estrogen receptor modulator, wherein the at least one treatment regimen is determined based on the APOE allelic profile in the subject, and based on the steroid hormone levels prior to disease diagnosis and on current steroid hormone levels in the subject. | 01-28-2010 |
| 20100022991 | System and device for maintaining physiological levels of steroid hormone in a subject - A system, device, or method is provided which maintains a substantially physiological level or a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The system, device, or method includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on pre-menopausal cyclic steroid hormone levels of the subject and on current cyclic steroid hormone levels of the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological cyclic pre-menopausal levels. The system, device, or methods can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100023344 | System and device for maintaining physiological levels of steroid hormone in a subject - A system, device, or method is provided which maintains a substantially physiological level or a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The system, device, or method includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on pre-menopausal cyclic steroid hormone levels of the subject and on current cyclic steroid hormone levels of the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological cyclic pre-menopausal levels. The system, device, or methods can be used for the treatment of a disease or condition in the mammalian subject. | 01-28-2010 |
| 20100030089 | Methods and systems for monitoring and modifying a combination treatment - Methods, computer program products, and systems are described that include monitoring at least one attribute of an individual during an artificial sensory experience while the individual is under the influence of a bioactive agent, identifying at least one characteristic of the artificial sensory experience that is proximate to a desired change in the at least one attribute of the individual, and/or modifying at least one of the artificial sensory experience or the bioactive agent at least partly based on the identifying at least one characteristic of the artificial sensory experience that is proximate to the desired change in the at least one attribute of the individual. | 02-04-2010 |
| 20100030185 | Remote controller for substance delivery system - Embodiments of a system including a remotely controlled substance delivery device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, a delivery device or related device may be placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. The concentration of a substance in the fluid to be delivered may be modified by a remote control signal. In selected embodiments, a magnetic field, an electric field, or electromagnetic control signal may be used. | 02-04-2010 |
| 20100035855 | Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject - A method for treating cardiovascular disease in a mammalian subject includes providing to the subject at least one treatment regimen including at least one estrogen receptor modulator, wherein the at least one treatment regimen is determined based on the APOE allelic profile in the subject, and based on the steroid hormone levels prior to disease diagnosis and on current steroid hormone levels in the subject. | 02-11-2010 |
| 20100036209 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 02-11-2010 |
| 20100036263 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 02-11-2010 |
| 20100036268 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 02-11-2010 |
| 20100036269 | Circulatory monitoring systems and methods - Systems and methods are described for obtaining and acting upon information indicative of circulatory health and related phenomena in human beings or other subjects. | 02-11-2010 |
| 20100038622 | CONNECTIBLE NANOTUBE CIRCUIT - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 02-18-2010 |
| 20100040187 | Heat pipe nuclear fission deflagration wave reactor cooling - Illustrative embodiments provide systems, applications, apparatuses, and methods related to nuclear fission deflagration wave reactor cooling. Illustrative embodiments and aspects include, without limitation, nuclear fission deflagration wave reactors, methods of transferring heat of a nuclear fission deflagration wave reactor, methods of transferring heat from a nuclear fission deflagration wave reactor, methods of transferring heat within a nuclear fission deflagration wave reactor, and the like. | 02-18-2010 |
| 20100040188 | Heat pipe nuclear fission deflagration wave reactor cooling - Illustrative embodiments provide systems, applications, apparatuses, and methods related to nuclear fission deflagration wave reactor cooling. Illustrative embodiments and aspects include, without limitation, nuclear fission deflagration wave reactors, methods of transferring heat of a nuclear fission deflagration wave reactor, methods of transferring heat from a nuclear fission deflagration wave reactor, methods of transferring heat within a nuclear fission deflagration wave reactor, and the like. | 02-18-2010 |
| 20100040546 | Biological targeting compositions and methods of using the same - Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described. | 02-18-2010 |
| 20100041014 | Biological targeting compositions and methods of using the same - Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described. | 02-18-2010 |
| 20100041133 | Biological targeting compositions and methods of using the same - Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described. | 02-18-2010 |
| 20100041964 | Methods and systems for monitoring and modifying a combination treatment - Methods, computer program products, and systems are described that include monitoring at least one health attribute of an individual during an artificial sensory experience, associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual, and/or modifying at least one of a bioactive agent or the artificial sensory experience at least partly based on associating a characteristic of the artificial sensory experience with the at least one health attribute of the individual. | 02-18-2010 |
| 20100042072 | Biological targeting compositions and methods of using the same - Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described. | 02-18-2010 |
| 20100052892 | Health-related signaling via wearable items - Systems and methods are described for configuring and using displays, speakers, or other output devices positioned by an article of clothing or other such structure wearable by a healthcare recipient, for example, in a clinic or residential care facility. | 03-04-2010 |
| 20100052897 | Health-related signaling via wearable items - Systems and methods are described for configuring and using displays, speakers, or other output devices positioned by an article of clothing or other such structure wearable by a healthcare recipient, for example, in a clinic or residential care facility. | 03-04-2010 |
| 20100052898 | Health-related signaling via wearable items - Systems and methods are described for configuring and using displays, speakers, or other output devices positioned by an article of clothing or other such structure wearable by a healthcare recipient, for example, in a clinic or residential care facility. | 03-04-2010 |
| 20100052915 | Health-related signaling via wearable items - Systems and methods are described for configuring and using displays, speakers, or other output devices positioned by an article of clothing or other such structure wearable by a healthcare recipient, for example, in a clinic or residential care facility. | 03-04-2010 |
| 20100056873 | Health-related signaling via wearable items - Systems and methods are described for configuring and using displays, speakers, or other output devices positioned by an article of clothing or other such structure wearable by a healthcare recipient, for example, in a clinic or residential care facility. | 03-04-2010 |
| 20100061976 | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject - A method is described for treating or preventing a bone loss disease or a bone loss disorder in a mammalian subject or reducing the incidence of a bone loss disease or a bone loss disorder or alleviating the symptoms thereof. The method includes providing to the mammalian subject at least one treatment regimen including at least one follicle-stimulating hormone modulator configured to and in an amount sufficient to reduce bioactivity or bioavailability of follicle-stimulating hormone in the mammalian subject. | 03-11-2010 |
| 20100062428 | Methods for collecting and detecting oligonucleotides - Methods, pharmaceutical compositions, and kits are provided which includes accurately sampling a RNA from a tissue of an animal and analyzing RNA in the tissue of the animal as an indicator of physiological state, infectious disease, neoplastic disease, autoimmune disease, inflammatory disease, cardiovascular disease, atherosclerotic disease, or neurological disease in the animal. A method is provided which includes administering at least one compound to an animal wherein the at least one compound is configured to prevent the cleavage of at least one tissue RNA by a ribonuclease. The method further includes collecting a sample of at least a portion of tissue from the animal. | 03-11-2010 |
| 20100065097 | Systems configured to deliver energy out of a living subject, and related appartusesand methods - Embodiments disclosed herein are directed to systems configured to deliver energy out of a living subject to power at least one external device, and related apparatuses, and methods of use. | 03-18-2010 |
| 20100067920 | Systems configured to transmit optical power signals transdermally out of a living subject, and devices and methods - In an embodiment, a system includes an internal optical power transmitter configured to be disposed within a living subject. The internal optical power transmitter includes a power source configured to provide electrical energy and an electrical-optical converter operably coupled to the power source. The electrical-optical converter may be configured to convert at least a portion of the electrical energy into one or more optical power signals transdermally transmittable out of the living subject. The system further includes an external optical-electrical converter configured to convert the one or more optical power signals into one or more electrical power signals and at least one external device configured to be operably coupled to the external optical-electrical converter and powered by the one or more electrical power signals. Embodiments of methods, biocompatible electrical-optical converters, and internal optical power transmitters are also disclosed. | 03-18-2010 |
| 20100068152 | Ex vivo modifiable particle or polymeric based final dosage form - Provided embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for administering a medicament to an animal is provided. The final dosage form includes the medicament, and a particle or polymeric material. The particle or polymeric material carries the medicament and is configured in a medicament-retention state. In medicament-retention state, the medicament is substantially not bioavailable to the animal if the final dosage form is administered to the animal. The particle or polymeric material is modifiable ex vivo by an exposure to a stimulus to a medicament-release state. In the medicament-release state, the medicament is substantially bioavailable to the animal if the final dosage form is administered to the animal. | 03-18-2010 |
| 20100068153 | Ex vivo activatable final dosage form - Provided embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for administering a medicament to an animal is provided. The final dosage form includes an outer layer, the medicament, and a release element. The release element configured in a medicament-holding state and modifiable ex vivo to a medicament-discharge state by an exposure to a stimulus. In an embodiment, the final dosage form includes a chamber substantially within the outer layer and carrying the medicament. In an embodiment, the final dosage form includes an indicator element configured to indicate an exposure of the release element to the stimulus. | 03-18-2010 |
| 20100068233 | Modifiable dosage form - Provided embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for delivering a medicament to an animal is provided. The final dosage form includes an outer layer. The final dosage form also includes a release element configured in a first medicament-release state and modifiable to a second medicament-release state upon an ex vivo exposure to a stimulus. The final dosage form further includes a chamber at least substantially within the outer layer and configured to carry the medicament. The final dosage form includes the medicament. The final dosage form may include an indicator element configured to indicate an exposure of the release element to the stimulus. | 03-18-2010 |
| 20100068235 | Individualizable dosage form - Provided embodiments include a final dosage form, an article of manufacture, and a method. A final dosage form for delivering a medicament to an animal is provided. The final dosage form includes an outer layer. The final dosage form also includes a release element configured in a first medicament-release state and modifiable to a second medicament-release state upon an ex vivo exposure to a stimulus. The final dosage form further includes a chamber at least substantially within the outer layer and configured to carry the medicament. The final dosage form further includes a containment element configured to retain the medicament within the final dosage form until the dosage form is administered to the animal. The final dosage form includes the medicament. The final dosage form may include an indicator element configured to indicate an exposure of the release element to the stimulus. | 03-18-2010 |
| 20100068254 | Modifying a medicament availability state of a final dosage form - Provided embodiments include a final dosage form, an article of manufacture, and method. A method of modifying a medicament availability state of a final dosage form is provided. The method includes initiating an exposure of a particle or polymeric material of the final dosage form to a stimulus. The initiated stimulus is selected to transform the particle or polymeric material from a medicament-retention state to a medicament-release state. | 03-18-2010 |
| 20100068256 | Ex vivo modifiable medicament release-substance - A described final dosage form includes a substance carrying a medicament in a first medicament-release state having a first bioavailability. The substance is modifiable ex vivo by an exposure to a first stimulus to carry the medicament in a second medicament-release state having a second bioavailability. The substance is modifiable ex vivo by an exposure to a second stimulus to carry the medicament in a third medicament-release state having a third bioavailability. The final dosage form includes another substance carrying another medicament in another first medicament-release state having another first bioavailability. The another substance is modifiable ex vivo by an exposure to another first stimulus to carry the another medicament in another second medicament-release state having another second bioavailability. The another substance is modifiable ex vivo by an exposure to another second stimulus to carry the another medicament in another third medicament-release state having another third bioavailability. | 03-18-2010 |
| 20100068266 | Ex vivo-modifiable multiple-release state final dosage form - Described embodiments include a final dosage form for administering a medicament to an animal, an article of manufacture, and method. A described final dosage form includes a medicament. The final dosage form also includes a release-control substance carrying the medicament in a first medicament-release state wherein the medicament has a first bioavailability to the animal if the final dosage form is administered to the animal. The release-control substance is modifiable ex vivo by an exposure to a first stimulus to carry the medicament in a second medicament-release state wherein the medicament has a second bioavailability to the animal if the final dosage form is administered to the animal. The release-control substance is modifiable ex vivo by an exposure to second stimulus to carry the medicament in a third medicament-release state wherein the medicament has a third bioavailability to the animal if the final dosage form is administered to the animal. | 03-18-2010 |
| 20100068275 | Personalizable dosage form - Provided embodiments include a final dosage form, an article of manufacture, and a method. A method of fulfilling a request specifying a dose of a medicament for an individual animal includes choosing pursuant to the request an instance of a final dosage form that includes the medicament. The method also includes selecting a stimulus effective to change a medicament-release state of a release element of the final dosage form. The method further includes initiating an ex vivo exposure of the release element of the chosen instance of the final dosage form to the selected stimulus. The method further includes the release element configured in a first medicament-release state and changeable to a second medicament-release state upon an ex vivo exposure to a stimulus. | 03-18-2010 |
| 20100068277 | Ex vivo modifiable multiple medicament final dosage form - Described embodiments include a final dosage form for administering a medicament to an animal, an article of manufacture, and method. A described final dosage form includes a dosage portion having a medicament and a release element in a first medicament-release state. The medicament has a first bioavailability to the animal. The release element is modifiable ex vivo to a second medicament-release state by an exposure to a stimulus, wherein the medicament has a second bioavailability to the animal. The final dosage form includes another dosage portion having another medicament and another release element in another first medicament-release state. In the another first medicament-release state, the another medicament has another first bioavailability to the animal. The another release element is modifiable ex vivo to another second medicament-release state by an exposure to another stimulus, wherein the another medicament has another second bioavailability to the animal. | 03-18-2010 |
| 20100068278 | Ex vivo modifiable medicament release-associations - Described embodiments include a final dosage form, an article of manufacture, and method. A described final dosage form includes a medicament, and a substance associated with the medicament in a first release-control state. In the first release-control state, the medicament has a first bioavailability to the animal. The substance is modifiable ex vivo by an exposure to a stimulus to associate with the medicament in a second release-control state, wherein the medicament has a second bioavailability to the animal. The final dosage form also includes another medicament, and another substance associated with the another medicament in another first release-control state. In the another first release-control state, the another medicament has another first bioavailability to the animal. The another substance is modifiable ex vivo by an exposure to another stimulus to associate with the another medicament in another second release-control state, wherein the another medicament has another second bioavailability. | 03-18-2010 |
| 20100068283 | Ex VIVO modifiable particle or polymeric material medicament carrier - Described embodiments include a final dosage form, an article of manufacture, and method. A final dosage form for administering a medicament to an animal is described. The final dosage form includes the medicament. The final dosage form also includes a particle or polymeric material carrying the medicament in a first medicament-release state wherein the medicament is available to the animal in a first bioavailability if the final dosage form is administered to the animal. The particle or polymeric material is modifiable ex vivo by an exposure to a stimulus to carry the medicament in a second medicament-release state wherein the medicament is available to the animal in a second bioavailability if the final dosage form is administered to the animal. In an embodiment, the final dosage form further includes a transport medium suitable for delivering the particle or polymeric material binding the medicament to the animal. | 03-18-2010 |
| 20100068808 | Tubular nanostructure targeted to cell membrane - Devices, compositions, and methods are described which provide a tubular nanostructure or a composite tubular nanostructure targeted to a lipid bilayer membrane. The tubular nanostructure includes a hydrophobic surface region flanked by two hydrophilic surface regions. The tubular nanostructure is configured to interact with a lipid bilayer membrane and form a pore in the lipid bilayer membrane. The tubular nanostructure may be targeted by including at least one ligand configured to bind to one or more cognates on the lipid bilayer membrane of a target cell. | 03-18-2010 |
| 20100069606 | Tubular nanostructure targeted to cell membrane - Devices, compositions, and methods are described which provide a tubular nanostructure targeted to a lipid bilayer membrane. The targeted tubular nanostructure can have a surface region configured to pass through a lipid bilayer membrane of a cell, a hydrophobic surface region flanked by two hydrophilic surface regions configured to form a pore in a lipid bilayer membrane of a cellular organelle, and at least one ligand configured to bind one or more cognates on the lipid bilayer membrane of the cellular organelle. The target cell can be, for example, a tumor cell, an infected cell, or a diseased cell in a subject. The tubular nanostructure can form a pore in the lipid bilayer membrane of the cellular organelle, e.g., mitochondria, which can permit transit or translocation of at least one compound across the membrane and cause cell death of the target cell. | 03-18-2010 |
| 20100069821 | Ex vivo modifiable medicament release-sites final dosage form - Described embodiments include a final dosage form, an article of manufacture, and method. A described final dosage form includes a dosage portion having a medicament, and a site and the medicament in a first association. In the first association, the medicament has a first bioavailability. The first association of the site and the medicament is modifiable ex vivo to a second association an exposure to a stimulus, wherein the medicament has a second bioavailability. The final dosage form includes another dosage portion having another medicament, and another site and the another medicament in another first association. In the another first association, the another medicament has another first bioavailability. The another first association is modifiable ex vivo to another second association of the another site and the another medicament by an exposure to another stimulus, wherein the another medicament has another second bioavailability. | 03-18-2010 |
| 20100069822 | System for ex vivo modification of medicament release state - Described embodiments include a system. A described system includes a computer-readable storage medium configured to indicate a stimulus to modify ex vivo a bioavailability of a medicament carried by a final dosage form based upon a selected medicament bioavailability of the final dosage form. The system also includes a holder configured to establish ex vivo of the animal a location of the final dosage form to receive the indicated stimulus from a stimulus source. The system further includes the stimulus source operable to provide the indicated stimulus. The system also includes a stimulation controller operable to regulate an ex vivo exposure of the final dosage form to the indicated stimulus. | 03-18-2010 |
| 20100069887 | Multiple chamber ex vivo adjustable-release final dosage form - Described embodiments include a final dosage form, an article of manufacture, and method. A described final dosage form includes a dosage portion having a chamber carrying a medicament. The dosage portion also has a release element in a first medicament-release state wherein the medicament has a first bioavailability to the animal. The release element is modifiable ex vivo to a second medicament-release state by an exposure to a stimulus, wherein the medicament has a second bioavailability to the animal. The final dosage form includes another dosage portion having another chamber carrying another medicament. The another dosage portion also has another release element in another first medicament-release state wherein the another medicament has another first bioavailability to the animal. The another release element is modifiable ex vivo to another second medicament-release state by an exposure to another stimulus, wherein the another medicament has another second bioavailability to the animal. | 03-18-2010 |
| 20100070002 | Systems configured to locate a photonic device disposed in a living subject, and related apparatuses and methods - In an embodiment, a system includes a biocompatible photonic device configured for disposal within a living subject and a location-indicating aid associated with the photonic device. The location-indicating aid is configured to facilitate locating the biocompatible photonic device within the living subject. Related apparatuses and methods of use are also disclosed. | 03-18-2010 |
| 20100070003 | Systems configured to power at least one device disposed in a living subject, and related apparatuses and methods - Embodiments disclosed herein are directed to systems configured to power at least one device disposed in a living subject, apparatuses configured to be disposed in a living subject and export power stored in an energy-storage device, and related methods of powering at least one device disposed in the living subject. | 03-18-2010 |
| 20100070939 | NANOTUBE CIRCUIT ANALYSIS SYSTEM AND METHOD - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 03-18-2010 |
| 20100076414 | Remote control of substance delivery system - Embodiments of a system including a remotely controlled substance delivery device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, a delivery device or related device may be placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. The concentration of a substance in the fluid to be delivered may be modified by a remote control signal. In selected embodiments, a magnetic field, an electric field, or electromagnetic control signal may be used. | 03-25-2010 |
| 20100076415 | Remote control of substance delivery system - Embodiments of a system including a remotely controlled substance delivery device and associated controller are described. Methods of use and control of the device are also disclosed. According to some embodiments, a delivery device or related device may be placed in an environment in order to pump a material into the environment or into an additional fluid handling structure within the device. Exemplary environments include a body of an organism, a body of water, or an enclosed volume of a fluid. The concentration of a substance in the fluid to be delivered may be modified by a remote control signal. In selected embodiments, a magnetic field, an electric field, or electromagnetic control signal may be used. | 03-25-2010 |
| 20100078014 | Method, composition, and system to control pH in pulmonary tissue of a subject - Methods, pharmaceutical compositions, and systems are provided which include a method for treating a pulmonary viral infectious disease in a subject. The method includes administering a pharmaceutical composition including at least one agent to a pulmonary tissue of the subject, wherein the pharmaceutical composition is administered as two or more distinct and non-overlapping particle size ranges configured to contact two or more levels of pulmonary tissue of the subject, wherein the at least one agent is configured to achieve a selected pH range in the two or more levels of pulmonary tissue of the subject. | 04-01-2010 |
| 20100078020 | Method, device, and system to control PH in pulmonary tissue of a subject - Methods, devices, and systems are provided which include an aerosol generator and a pharmaceutical composition including a membrane selective for a charged ion configured to achieve a selected pH of a pulmonary tissue in a subject. The methods, devices, or systems which include the membrane may be configured to alter selectivity for the charged ion in response to a sensed condition in the pulmonary tissue. | 04-01-2010 |
| 20100078995 | Beam power with multipoint reception - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079005 | Beam power with multiple power zones - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079008 | Beam power with broadcaster impingement detection - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079009 | Beam power with multipoint broadcast - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079010 | Beam power for local receivers - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079011 | Beam power with beam redirection - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100079012 | Beam power with receiver impingement detection - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 04-01-2010 |
| 20100080760 | Method, device, and system to control pH in pulmonary tissue of a subject - Methods, devices, and systems are provided which include an aerosol generator and a pharmaceutical composition including a membrane selective for a charged ion configured to achieve a selected pH of a pulmonary tissue in a subject. The methods, devices, or systems which include the membrane may be configured to alter selectivity for the charged ion in response to a sensed condition in the pulmonary tissue. | 04-01-2010 |
| 20100081190 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081915 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081916 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081919 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081923 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081924 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081925 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081926 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081927 | Histological facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081928 | Histological Facilitation systems and methods - Systems, methods, and other modalities are described for generating or otherwise handling images or other data indicating (a) an extraction of chemically treated tissue frozen in vivo, (b) a treatment of a tissue sample in a chamber extended into tissue of an organism, and/or (c) cells to which an optical enhancement material was applied in vivo. Several contexts in which such indications facilitate histological evaluation are likewise described. | 04-01-2010 |
| 20100081954 | Method, device, and system to control pH in pulmonary tissue of a subject - Methods, systems, and devices are provided which include receiving data or providing data, wherein the data regards a physical condition affecting one or more subjects. The data can inform administration of a pharmaceutical composition in response to the physical condition, wherein the pharmaceutical composition is configured to contact pulmonary tissue to treat a pulmonary disease or condition in the one or more subjects. The data regarding the physical condition may be acquired prior to the subject entering an environment where the physical condition exists. | 04-01-2010 |
| 20100081956 | Method, composition, and system to control pH in pulmonary tissue of a subject - Methods, pharmaceutical compositions, and systems are provided which include a method for treating a pulmonary viral infectious disease in a subject. The method includes administering a pharmaceutical composition including at least one agent to a pulmonary tissue of the subject, wherein the pharmaceutical composition is administered as two or more distinct and non-overlapping particle size ranges configured to contact two or more levels of pulmonary tissue of the subject, wherein the at least one agent is configured to achieve a selected pH range in the two or more levels of pulmonary tissue of the subject. | 04-01-2010 |
| 20100081957 | Method, device, and system to control pH in pulmonary tissue of a subject - Methods, systems, and devices are provided which include receiving data or providing data, wherein the data regards a physical condition affecting one or more subjects. The data can inform administration of a pharmaceutical composition in response to the physical condition, wherein the pharmaceutical composition is configured to contact pulmonary tissue to treat a pulmonary disease or condition in the one or more subjects. The data regarding the physical condition may be acquired prior to the subject entering an environment where the physical condition exists. | 04-01-2010 |
| 20100083631 | Hybrid propulsive engine including at least one independently rotatable turbine stator - One aspect relates to a hybrid propulsive technique, comprising providing a flow of a working fluid through at least a portion of an at least one jet engine. The at least one jet engine includes an at least one turbine section, wherein the at least one turbine section includes at least one turbine stage. The at least one turbine stage includes an at least one turbine rotor and an at least one independently rotatable turbine stator. The hybrid propulsive technique further involves extracting energy at least partially in the form of electrical power from the working fluid, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further comprises rotating an at least one at least one independently rotatable turbine stator at least partially responsive to the converting the at least a portion of the electrical power to torque. | 04-08-2010 |
| 20100083632 | Hybrid propulsive engine including at least one independently rotatable compressor rotor - One aspect relates to a hybrid propulsive technique, comprising providing at least some first thrust associated with a flow of a working fluid through at least a portion of an at least one jet engine. The hybrid propulsive technique includes extracting energy at least partially in the form of electrical power from the working fluid, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further includes rotating an at least one substantially axial-flow independently rotatable compressor rotor at least partially responsive to the converting the at least a portion of the electrical power to torque. | 04-08-2010 |
| 20100083668 | Hybrid propulsive engine including at least one independently rotatable compressor stator - One aspect relates to a hybrid propulsive technique, comprising providing a flow of a working fluid through at least a portion of an at least one jet engine. The hybrid propulsive technique comprises extracting energy from the working fluid that is at least partially converted into electrical power, and converting at least a portion of the electrical power to a torque. The hybrid propulsive technique also comprises rotating an at least one independently rotatable compressor stator at least partially responsive to the converting the at least a portion of the electrical power to the torque. | 04-08-2010 |
| 20100083669 | Hybrid propulsive engine including at least one independently rotatable propeller/fan - One aspect relates to a hybrid propulsive technique comprising providing at least some first thrust associated with a flow of a working fluid through at least a portion of an at least one axial flow jet engine. The hybrid propulsive technique comprises extracting energy from the working fluid that is at least partially converted into electrical power, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further comprises rotating an at least one independently rotatable propeller/fan of at least one rotatable propeller/fan assembly at least partially responsive to the converting the at least a portion of the electrical power to torque, wherein the rotating of the at least one independently rotatable propeller/fan of the at least one rotatable propeller/fan assembly is arranged to produce at least some second thrust. | 04-08-2010 |
| 20100092463 | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject - A method is described for treating or preventing a bone loss disease or a bone loss disorder in a mammalian subject or reducing the incidence of a bone loss disease or a bone loss disorder or alleviating the symptoms thereof. The method includes providing to the mammalian subject at least one treatment regimen including at least one follicle-stimulating hormone modulator configured to and in an amount sufficient to reduce bioactivity or bioavailability of follicle-stimulating hormone in the mammalian subject. | 04-15-2010 |
| 20100102921 | Electrical closing switch made from reactive composite materials - Devices and components that can interact with or modify propagation of electromagnetic waves are provided. The design, fabrication and structures of the devices exploit the properties of reactive composite materials (RCM) and reaction products thereof. | 04-29-2010 |
| 20100103373 | Vision modification with reflected image - Various embodiments of methods and systems for improving and enhancing vision are disclosed. Adjustable lenses or optical systems may be used to provide adaptive vision modification. In some embodiments, vision modification may be responsive to the current state of the user's visual system. Certain embodiments provide correction of the subject's near and far vision. Other embodiments provide enhancement of vision beyond the physiological ranges of focal length or magnification. | 04-29-2010 |
| 20100104493 | Reactive composite material structures with endothermic reactants - Devices and components that can interact with or modify propagation of electromagnetic waves are provided. The design, fabrication and structures of the devices exploit the properties of reactive composite materials (RCM) and reaction products thereof. | 04-29-2010 |
| 20100104820 | Optical and metamaterial devices based on reactive composite materials - Devices and components that can interact with or modify propagation of electromagnetic waves are provided. The design, fabrication and structures of the devices exploit the properties of reactive composite materials (RCM) and reaction products thereof. | 04-29-2010 |
| 20100104822 | Optical and metamaterial devices based on reactive composite materials - Devices and components that can interact with or modify propagation of electromagnetic waves are provided. The design, fabrication and structures of the devices exploit the properties of reactive composite materials (RCM) and reaction products thereof. | 04-29-2010 |
| 20100104823 | Reactive composite material structures with multiple reaction-propagation circuits - Devices and components that can interact with or modify propagation of electromagnetic waves are provided. The design, fabrication and structures of the devices exploit the properties of reactive composite materials (RCM) and reaction products thereof. | 04-29-2010 |
| 20100104834 | Foam-like structures based on reactive composite materials - Articles having porous or foam-like elements are provided. The design, fabrication and structures of the articles exploit properties of reactive composite materials (RCM) and their reaction products. In particular, fluids generated by reacting RCM are utilized to create or fill voids in the porous or foam-like elements. | 04-29-2010 |
| 20100104848 | Foam-like structures based on reactive composite materials - Articles having porous or foam-like elements are provided. The design, fabrication and structures of the articles exploit properties of reactive composite materials (RCM) and their reaction products. In particular, fluids generated by reacting RCM are utilized to create or fill voids in the porous or foam-like elements. | 04-29-2010 |
| 20100107651 | Hybrid propulsive engine including at least one independently rotatable compressor stator - One aspect relates to a hybrid propulsive technique, comprising providing a flow of a working fluid through at least a portion of an at least one jet engine. The hybrid propulsive technique comprises extracting energy from the working fluid that is at least partially converted into electrical power, and converting at least a portion of the electrical power to a torque. The hybrid propulsive technique also comprises rotating an at least one independently rotatable compressor stator at least partially responsive to the converting the at least a portion of the electrical power to the torque. | 05-06-2010 |
| 20100107652 | Hybrid propulsive engine including at least one independently rotatable compressor rotor - One aspect relates to a hybrid propulsive technique, comprising providing at least some first thrust associated with a flow of a working fluid through at least a portion of an at least one axial flow jet engine. The hybrid propulsive technique includes extracting energy at least partially in the form of electrical power from the working fluid, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further includes rotating an at least one substantially axial-flow independently rotatable compressor rotor at least partially responsive to the converting the at least a portion of the electrical power to torque. | 05-06-2010 |
| 20100108806 | Hybrid propulsive engine including at least one independently rotatable propeller/fan - One aspect relates to a method of reducing noise for an aircraft. The method includes determining a mode of operation of the aircraft or the engine. The method also includes controlling a hybrid jet engine, based on the mode of operation, to at least partially use electrically generated torque to generate thrust. | 05-06-2010 |
| 20100109536 | LED-based secondary general illumination lighting color slaved to primary general illumination lighting - One aspect relates to combining an at least one primary general illumination lighting with an at least one LED-based secondary general illumination lighting. The aspect further comprises sensing an at least one sensed electric characteristics used to produce the at least one primary general illumination lighting. The aspect further comprises controlling an optical characteristic of the at least one LED-based secondary general illumination lighting at least partially responsive to the sensing the at least one sensed electric characteristics used to produce the at least one primary general illumination lighting. | 05-06-2010 |
| 20100110682 | Led-based secondary general illumination lighting color slaved to alternate general illumination lighting - One aspect relates to combining an at least one LED-based secondary general illumination lighting with an at least one primary general illumination lighting to at least partially provide an at least one combined general illumination lighting. The aspect further comprises sensing one or more sensed optical characteristics of an at least one alternate general illumination lighting. The aspect further comprises controlling at least one controlled optical characteristics of the at least one LED-based secondary general illumination lighting to control the at least one combined general illumination lighting at least partially responsive to the sensing the one or more sensed optical characteristics of an at least one alternate general illumination lighting. | 05-06-2010 |
| 20100111471 | Photonic band gap router - An arrangement includes a photonic band-gap assembly comprising at least one input wave guide and at least one output wave guides, and at least one routing element responsive to signals to selectively route a signal from the input wave guide to one or more of the output wave guides. | 05-06-2010 |
| 20100117000 | Variable multi-stage waveform detector - A variable waveform detector may include multiple stages. | 05-13-2010 |
| 20100119455 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100119456 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121176 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121177 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121185 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121186 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121187 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100121581 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 05-13-2010 |
| 20100125176 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125177 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125178 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125179 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125180 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125181 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125417 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125418 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125419 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100125420 | Food content detector - A system may include utensil means for portioning a foodstuff into a first portion and a second portion, a means for detecting a first portion size for the first portion with the utensil means, a means for detecting a second portion size for the second portion with the utensil means, and a means for determining a cumulative amount of portioned foodstuff based upon the first portion size and the second portion size. | 05-20-2010 |
| 20100126178 | Hybrid propulsive engine including at least one independently rotatable turbine stator - One aspect relates to a hybrid propulsive technique, comprising providing a flow of a working fluid through at least a portion of an at least one jet engine. The at least one jet engine includes an at least one turbine section, wherein the at least one turbine section includes at least one turbine stage. The at least one turbine stage includes an at least one turbine rotor and an at least one independently rotatable turbine stator. The hybrid propulsive technique further involves extracting energy at least partially in the form of electrical power from the working fluid, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further comprises rotating an at least one at least one independently rotatable turbine stator at least partially responsive to the converting the at least a portion of the electrical power to torque. | 05-27-2010 |
| 20100127507 | Electromagnetic engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 05-27-2010 |
| 20100140943 | Device for storage of intraluminally generated power - A device for storing power generated from intraluminal pressure changes may comprise: (a) an intraluminal pressure change-receiving structure operably coupled to the generator; (b) a intraluminal generator; and (c) an energy storage apparatus. | 06-10-2010 |
| 20100140956 | Method for generation of power from intraluminal pressure changes - A method for extracting power from intraluminal pressure changes may comprise one or more of the following steps: (a) receiving an intraluminal pressure change; (b) converting the intraluminal pressure change into energy with an intraluminal generator; and (c) storing the energy in an energy storage apparatus. | 06-10-2010 |
| 20100140957 | Method for generation of power from intraluminal pressure changes - A method for generating power from intraluminal pressure changes may comprise one or more of the following steps: (a) receiving an intraluminal pressure change; and (b) converting the intraluminal pressure change into energy with an intraluminal generator. | 06-10-2010 |
| 20100140958 | Method for powering devices from intraluminal pressure changes - A method for extracting power from intraluminal pressure changes may comprise one or more of the following steps: (a) receiving an intraluminal pressure change; (b) converting an intraluminal pressure change into energy with an intraluminal generator; and (c) providing the energy to a power utilization device. | 06-10-2010 |
| 20100140959 | Device and system for generation of power from intraluminal pressure changes - A device for generating power from intraluminal pressure changes may comprise: (a) a generator configured for intraluminal disposal; and (b) an intraluminal pressure change-receiving structure. | 06-10-2010 |
| 20100141052 | System for powering devices from intraluminal pressure changes - A system for utilizing power extracted from intraluminal pressure changes may comprise: (a) an intraluminal generator; (b) an intraluminal pressure change-receiving structure operably coupled to the intraluminal generator; and (c) a power utilization device. | 06-10-2010 |
| 20100142031 | MAGNETIC CONTROL OF SURFACE STATES - A magnetic field may be applied to a plasmon path to affect plasmon propagation. | 06-10-2010 |
| 20100145412 | System, devices, and methods including actively-controllable sterilizing excitation delivery implants - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-10-2010 |
| 20100150292 | Controllable long term operation of a nuclear reactor - Exemplary embodiments provide automated nuclear fission reactors and methods for their operation. Exemplary embodiments and aspects include, without limitation, re-use of nuclear fission fuel, alternate fuels and fuel geometries, modular fuel cores, fast fluid cooling, variable burn-up, programmable nuclear thermostats, fast flux irradiation, temperature-driven surface area/volume ratio neutron absorption, low coolant temperature cores, refueling, and the like. | 06-17-2010 |
| 20100163020 | Method for administering an inhalable compound - A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position. | 07-01-2010 |
| 20100163029 | Method for administering an inhalable compound - A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position. | 07-01-2010 |
| 20100163039 | Method for administering an inhalable compound - A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position. | 07-01-2010 |
| 20100163040 | Method for administering an inhalable compound - A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position. | 07-01-2010 |
| 20100163041 | Method for administering an inhalable compound - A method may include dispensing a dose of an inhalable compound according to a dosing instruction set; and maintaining a hands-free article for dispensing the inhalable compound in an operable dispensing position. | 07-01-2010 |
| 20100169022 | Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity - Methods and systems such as those described herein include accepting input, identifying CYP450-family enzymes, identifying at least one modulator of an enzyme, and communicating one or more treatments to a system user. | 07-01-2010 |
| 20100174346 | System, devices, and methods including actively-controllable sterilizing excitation delivery implants - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 07-08-2010 |
| 20100177279 | Vision modification with reflected image - Various embodiments of methods and systems for improving and enhancing vision are disclosed. Adjustable lenses or optical systems may be used to provide adaptive vision modification. In some embodiments, vision modification may be responsive to the current state of the user's visual system. Certain embodiments provide correction of the subject's near and far vision. Other embodiments provide enhancement of vision beyond the physiological ranges of focal length or magnification. | 07-15-2010 |
| 20100187224 | Microwave processing systems and methods - Generally and not exclusively, a method for controlling a process condition of at least one item within a microwave chamber may include receiving one or more initial values of one or more dynamically variable heatability properties for the at least one item in the microwave chamber, applying one or more microwave energy beams to the at least one item in the microwave chamber, remotely monitoring a spatial variation of the one or more dynamically variable heatability properties for the at least one item in the microwave chamber at least one of simultaneously with or following the applying of the one or more microwave energy beams, and estimating the process condition for microwaving the at least one item in the microwave chamber based at least partially on the monitoring of the one or more dynamically variable heatability properties for the at least one item in the microwave chamber. | 07-29-2010 |
| 20100187304 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100189219 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100189224 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191091 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191092 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191093 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191094 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191105 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100191107 | Diagnostic delivery service - Systems, methods, and other modalities are described for (a) obtaining an indication relating to an emission module (which may be dangerous, e.g.) or its user (who may be untrained, e.g.) and for (b) configuring the module or causing an irradiation (for imaging, e.g.) in response to the indication. | 07-29-2010 |
| 20100207012 | Multi-stage waveform detector - A waveform detector may include multiple stages. | 08-19-2010 |
| 20100208861 | Method and system for providing fuel in a nuclear reactor - Exemplary embodiments provide automated nuclear fission reactors and methods for their operation. Exemplary embodiments and aspects include, without limitation, re-use of nuclear fission fuel, alternate fuels and fuel geometries, modular fuel cores, fast fluid cooling, variable burn-up, programmable nuclear thermostats, fast flux irradiation, temperature-driven surface area/volume ratio neutron absorption, low coolant temperature cores, refueling, and the like. | 08-19-2010 |
| 20100216226 | Device, system, and method for controllably reducing inflammatory mediators in a subject - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-26-2010 |
| 20100217172 | Device, system, and method for controllably reducing inflammatory mediators in a subject - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-26-2010 |
| 20100217173 | Device, system, and method for controllably reducing inflammatory mediators in a subject - Devices, systems, and methods are provided for controlling an inflammatory response in a subject. Extracorporeal devices, systems, and methods are provided that alter the functional structure of one or more inflammatory mediators in the peripheral blood of the subject. The device or system is useful in a method for treating an inflammatory disease or condition in the subject. | 08-26-2010 |
| 20100218315 | Medical displaceable contouring mechanism - One aspect relates to reducing a pressure differential across one or more supporting surfaces of a body surface of an individual at least partially by displacing at least one displaceable contouring unit to at least partially conform to one or more contours of the body surface of the individual. Certain aspects can relate to stabilizing at least the one or more supporting surfaces of the body surface of the individual at least partially with at least one of the at least one displaceable contouring unit Other aspects can relate to relatively displacing at least one displaceable contouring unit with respect to a medical device portion based at least in part on a contour of an individual to support at least a portion of the individual while limiting pressure applied to the individual. | 09-02-2010 |
| 20100219393 | Connectible nanotube circuit - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 09-02-2010 |
| 20100220382 | Magnetic control of surface states - A magnetic field may be applied to a plasmon path to affect plasmon propagation. | 09-02-2010 |
| 20100228234 | Device for actively removing a target cell from blood or lymph of a vertebrate subject - Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region, the at least one reactive component configured to modulate a physiological effect of the one or more target cell types in the vertebrate subject; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen; wherein the at least one controller is configured to open or close the at least one controllable flow barrier in response to the one or more sensor. | 09-09-2010 |
| 20100233781 | Tubular nanostructure targeted to cell membrane - Devices, compositions, and methods are described which provide a tubular nanostructure targeted to a lipid bilayer membrane. The targeted tubular nanostructure can have a surface region configured to pass through a lipid bilayer membrane of a cell, a hydrophobic surface region flanked by two hydrophilic surface regions configured to form a pore in a lipid bilayer membrane of a cellular organelle, and at least one ligand configured to bind one or more cognates on the lipid bilayer membrane of the cellular organelle. The target cell can be, for example, a tumor cell, an infected cell, or a diseased cell in a subject. The tubular nanostructure can form a pore in the lipid bilayer membrane of the cellular organelle, e.g., mitochondria, which can permit transit or translocation of at least one compound across the membrane and cause cell death of the target cell. | 09-16-2010 |
| 20100234792 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-16-2010 |
| 20100234793 | Systems, devices and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-16-2010 |
| 20100240017 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241048 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241049 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241050 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241051 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241052 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241053 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241054 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100241055 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-23-2010 |
| 20100249692 | Systems, devices, and methods including infection-Fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 09-30-2010 |
| 20100254501 | Traveling wave nuclear fission reactor, fuel assembly, and method of controlling burnup therein - A traveling wave nuclear fission reactor, fuel assembly, and a method of controlling burnup therein. In a traveling wave nuclear fission reactor, a nuclear fission reactor fuel assembly comprises a plurality of nuclear fission fuel rods that are exposed to a deflagration wave burnfront that, in turn, travels through the fuel rods. The excess reactivity is controlled by a plurality of movable neutron absorber structures that are selectively inserted into and withdrawn from the fuel assembly in order to control the excess reactivity and thus the location, speed and shape of the burnfront. Controlling location, speed and shape of the burnfront manages neutron fluence seen by fuel assembly structural materials in order to reduce risk of temperature and irradiation damage to the structural materials. | 10-07-2010 |
| 20100254502 | Traveling wave nuclear fission reactor, fuel assembly, and method of controlling burnup therein - A traveling wave nuclear fission reactor, fuel assembly, and a method of controlling burnup therein. In a traveling wave nuclear fission reactor, a nuclear fission reactor fuel assembly comprises a plurality of nuclear fission fuel rods that are exposed to a deflagration wave burnfront that, in turn, travels through the fuel rods. The excess reactivity is controlled by a plurality of movable neutron absorber structures that are selectively inserted into and withdrawn from the fuel assembly in order to control the excess reactivity and thus the location, speed and shape of the burnfront. Controlling location, speed and shape of the burnfront manages neutron fluence seen by fuel assembly structural materials in order to reduce risk of temperature and irradiation damage to the structural materials. | 10-07-2010 |
| 20100255057 | Device for actively removing a target cell from blood or lymph of a vertebrate subject - Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region, the at least one reactive component configured to modulate a physiological effect of the one or more target cell types in the vertebrate subject; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen; wherein the at least one controller is configured to open or close the at least one controllable flow barrier in response to the one or more sensor. | 10-07-2010 |
| 20100260303 | Method and system for the thermoelectric conversion of nuclear reactor generated heat - A method and system for the thermoelectric conversion of nuclear reactor generated heat including upon a nuclear reactor system shutdown event, thermoelectrically converting nuclear reactor generated heat to electrical energy and supplying the electrical energy to a mechanical pump of the nuclear reactor system. | 10-14-2010 |
| 20100260304 | Method, system, and apparatus for the thermoelectric conversion of gas cooled nuclear reactor generated heat - A method, system, and apparatus for the thermoelectric conversion of nuclear reactor generated heat including thermoelectrically converting gas cooled nuclear reactor generated heat to electrical energy and supplying the electrical energy to an operation system of the nuclear reactor system. | 10-14-2010 |
| 20100260305 | Method, system, and apparatus for the thermoelectric conversion of gas cooled nuclear reactor generated heat - A method, system, and apparatus for the thermoelectric conversion of nuclear reactor generated heat including thermoelectrically converting gas cooled nuclear reactor generated heat to electrical energy and supplying the electrical energy to an operation system of the nuclear reactor system. | 10-14-2010 |
| 20100260306 | Method and system for the thermoelectric conversion of nuclear reactor generated heat - A method and system for the thermoelectric conversion of nuclear reactor generated heat including upon a nuclear reactor system shutdown event, thermoelectrically converting nuclear reactor generated heat to electrical energy and supplying the electrical energy to a mechanical pump of the nuclear reactor system. | 10-14-2010 |
| 20100260307 | Method and system for the thermoelectric conversion of nuclear reactor generated heat - A method and system for the thermoelectric conversion of nuclear reactor generated heat including upon a nuclear reactor system shutdown event, thermoelectrically converting nuclear reactor generated heat to electrical energy and supplying the electrical energy to a mechanical pump of the nuclear reactor system. | 10-14-2010 |
| 20100260308 | Method, system, and apparatus for selectively transferring thermoelectrically generated electric power to nuclear reactor operation systems - A method, system, and apparatus for the selective transfer of thermoelectrically generated electric power to operation systems of a nuclear reactor system including thermoelectrically converting nuclear reactor generated heat to electrical energy and selectively transferring the electrical energy to at least one operation system of the nuclear reactor system. | 10-14-2010 |
| 20100260309 | Method, System, and apparatus for selectively transferring thermoelectrically generated electric power to nuclear reactor operation systems - A method, system, and apparatus for the selective transfer of thermoelectrically generated electric power to operation systems of a nuclear reactor system including thermoelectrically converting nuclear reactor generated heat to electrical energy and selectively transferring the electrical energy to at least one operation system of the nuclear reactor system. | 10-14-2010 |
| 20100266084 | Nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same - A nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same. The fuel assembly comprises an enclosure adapted to enclose a porous nuclear fuel body having the volatile fission product therein. A fluid control subassembly is coupled to the enclosure and adapted to control removal of at least a portion of the volatile fission product from the porous nuclear fuel body. In addition, the fluid control subassembly is capable of circulating a heat removal fluid through the porous nuclear fuel body in order to remove heat generated by the nuclear fuel body. | 10-21-2010 |
| 20100266085 | Nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system - A nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system. The flow control assembly is coupled to a nuclear fission module capable of producing a traveling burn wave at a location relative to the nuclear fission module. The flow control assembly controls flow of a fluid in response to the location relative to the nuclear fission module. The flow control assembly comprises a flow regulator subassembly configured to be operated according to an operating parameter associated with the nuclear fission module. In addition, the flow regulator subassembly is reconfigurable according to a predetermined input to the flow regulator subassembly. Moreover, the flow control assembly comprises a carriage subassembly coupled to the flow regulator subassembly for adjusting the flow regulator subassembly to vary fluid flow into the nuclear fission module. | 10-21-2010 |
| 20100266086 | Nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system - A nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system. The flow control assembly is coupled to a nuclear fission module capable of producing a traveling burn wave at a location relative to the nuclear fission module. The flow control assembly controls flow of a fluid in response to the location relative to the nuclear fission module. The flow control assembly comprises a flow regulator subassembly configured to be operated according to an operating parameter associated with the nuclear fission module. In addition, the flow regulator subassembly is reconfigurable according to a predetermined input to the flow regulator subassembly. Moreover, the flow control assembly comprises a carriage subassembly coupled to the flow regulator subassembly for adjusting the flow regulator subassembly to vary fluid flow into the nuclear fission module. | 10-21-2010 |
| 20100266087 | Nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system - A nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system. The flow control assembly is coupled to a nuclear fission module capable of producing a traveling burn wave at a location relative to the nuclear fission module. The flow control assembly controls flow of a fluid in response to the location relative to the nuclear fission module. The flow control assembly comprises a flow regulator subassembly configured to be operated according to an operating parameter associated with the nuclear fission module. In addition, the flow regulator subassembly is reconfigurable according to a predetermined input to the flow regulator subassembly. Moreover, the flow control assembly comprises a carriage subassembly coupled to the flow regulator subassembly for adjusting the flow regulator subassembly to vary fluid flow into the nuclear fission module. | 10-21-2010 |
| 20100266088 | Nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system - A nuclear fission reactor, flow control assembly, methods therefor and a flow control assembly system. The flow control assembly is coupled to a nuclear fission module capable of producing a traveling burn wave at a location relative to the nuclear fission module. The flow control assembly controls flow of a fluid in response to the location relative to the nuclear fission module. The flow control assembly comprises a flow regulator subassembly configured to be operated according to an operating parameter associated with the nuclear fission module. In addition, the flow regulator subassembly is reconfigurable according to a predetermined input to the flow regulator subassembly. Moreover, the flow control assembly comprises a carriage subassembly coupled to the flow regulator subassembly for adjusting the flow regulator subassembly to vary fluid flow into the nuclear fission module. | 10-21-2010 |
| 20100266089 | Nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same - A nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same. The fuel assembly comprises an enclosure adapted to enclose a porous nuclear fuel body having the volatile fission product therein. A fluid control subassembly is coupled to the enclosure and adapted to control removal of at least a portion of the volatile fission product from the porous nuclear fuel body. In addition, the fluid control subassembly is capable of circulating a heat removal fluid through the porous nuclear fuel body in order to remove heat generated by the nuclear fuel body. | 10-21-2010 |
| 20100266090 | Nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same - A nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same. The fuel assembly comprises an enclosure adapted to enclose a porous nuclear fuel body having the volatile fission product therein. A fluid control subassembly is coupled to the enclosure and adapted to control removal of at least a portion of the volatile fission product from the porous nuclear fuel body. In addition, the fluid control subassembly is capable of circulating a heat removal fluid through the porous nuclear fuel body in order to remove heat generated by the nuclear fuel body. | 10-21-2010 |
| 20100266091 | Nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same - A nuclear fission reactor fuel assembly and system configured for controlled removal of a volatile fission product and heat released by a burn wave in a traveling wave nuclear fission reactor and method for same. The fuel assembly comprises an enclosure adapted to enclose a porous nuclear fuel body having the volatile fission product therein. A fluid control subassembly is coupled to the enclosure and adapted to control removal of at least a portion of the volatile fission product from the porous nuclear fuel body. In addition, the fluid control subassembly is capable of circulating a heat removal fluid through the porous nuclear fuel body in order to remove heat generated by the nuclear fuel body. | 10-21-2010 |
| 20100268199 | Device for passively removing a target component from blood or lymph of a vertebrate subject - Devices, systems, and methods are described herein for controlling or modulating the levels of one or more target components in the blood and/or lymph of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to fluid flow into the at least one lumen; at least one first reservoir disposed within the body and configured to include one or more bifunctional tags, wherein the one or more bifunctional tags are configured to selectively bind to one or more target components in one or more of blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; and at least one second reservoir disposed in the at least one treatment region and configured to include one or more reactive components, wherein the one or more reactive components are configured to sequester the one or more bifunctional tags when bound to the one or more target components. | 10-21-2010 |
| 20100274202 | Systems and methods for automatically inserting a needle into a living subject - Embodiments disclosed herein are directed to systems and methods for automatically inserting a needle into an insertion-target region of a living subject in response to a machine-vision system locating the insertion-target region. In an embodiment, a needle insertion system includes a moveable needle configured to be inserted into a living subject, a machine-vision system configured to locate an insertion-target region of the living subject, control electrical circuitry, and an actuator coupled to the control electrical circuitry. The control electrical circuitry may be coupled to the machine-vision system to receive location information therefrom about the insertion-target region, and configured to output needle targeting instructions. The actuator may be coupled to the control electrical circuitry to receive the needle targeting instructions therefrom and coupled to the moveable needle. The actuator may be configured to move the moveable needle to the insertion-target region automatically in response to receiving the needle targeting instructions from the control electrical circuitry. | 10-28-2010 |
| 20100280332 | Methods and systems for monitoring bioactive agent use - Methods, computer program products, and systems are described that include accepting at least one indication of a bioactive agent use by an individual and/or assigning an artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual. | 11-04-2010 |
| 20100280416 | Shape sensing clothes to inform the wearer of a condition - A garment may be configured with one or more sensors and circuitry to communicate information related to a physiological condition to the user. | 11-04-2010 |
| 20100280686 | Awarding privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100280688 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280689 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280690 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280691 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280692 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280693 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle; and allocating a standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle, wherein the standing is allocated upon receipt of the status. | 11-04-2010 |
| 20100280703 | Awarding Privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100280704 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, receiving a status indicative of combustible fuel utilization in comparison to electricity utilization for a vehicle and conveying a standing, the standing based upon the status indicative of combustible fuel utilization in comparison to electricity utilization for the vehicle. | 11-04-2010 |
| 20100280705 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, transmitting to an off-site entity a status indicative of combustible fuel utilization in comparison to electricity utilization from a vehicle. | 11-04-2010 |
| 20100280706 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, querying a hybrid vehicle for at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for the vehicle. | 11-04-2010 |
| 20100280707 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle and forwarding to an off-site entity the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle. | 11-04-2010 |
| 20100280708 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, transmitting to an off-site entity at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization from a hybrid vehicle. | 11-04-2010 |
| 20100280709 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, receiving a status indicative of combustible fuel utilization in comparison to electricity utilization for a vehicle and forwarding to an off-site entity the status indicative of combustible fuel utilization in comparison to electricity utilization for the vehicle. | 11-04-2010 |
| 20100280885 | Awarding privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100280886 | Awarding privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at Least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100280887 | Awarding privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100280888 | Awarding privileges to a vehicle based upon one or more fuel utilization characteristics - A device may include a determination module for determining at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for propelling a hybrid vehicle; and a transmitter coupled with the determination module for transmitting the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the hybrid vehicle to an off-site entity. | 11-04-2010 |
| 20100289263 | Free piston electromagnetic engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 11-18-2010 |
| 20100292629 | Systems, devices, and methods including infection-fighting and monitoring shunts - Systems, devices, methods, and compositions are described for providing an actively controllable shunt configured to, for example, monitor, treat, or prevent an infection. | 11-18-2010 |
| 20100294825 | Steerable surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one delivery mechanism adapted to deliver surgical fasteners, the delivery mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body organ/tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-25-2010 |
| 20100294826 | Gentle touch surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical fasteners, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body organ/tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-25-2010 |
| 20100294827 | Maneuverable surgical stapler - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one delivery mechanism adapted to deliver surgical fasteners, the delivery mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical fasteners containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 11-25-2010 |
| 20100295372 | Methods, devices and systems for transmission between an implanted device and an external device - Embodiments disclosed herein are directed to systems including an internal power transmitter that delivers energy out of a living subject to power at least one external device that is in communication with the internal power transmitter, and related apparatuses, devices, and methods of use. | 11-25-2010 |
| 20100298766 | Device for passively removing a target component from blood or lymph of a vertebrate subject - Devices, systems, and methods are described herein for controlling or modulating the levels of one or more target components in the blood and/or lymph of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to fluid flow into the at least one lumen; at least one first reservoir disposed within the body and configured to include one or more bifunctional tags, wherein the one or more bifunctional tags are configured to selectively bind to one or more target components in one or more of blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; and at least one second reservoir disposed in the at least one treatment region and configured to include one or more reactive components, wherein the one or more reactive components are configured to sequester the one or more bifunctional tags when bound to the one or more target components. | 11-25-2010 |
| 20100300560 | Water alteration structure and system having heat transfer conduit - A system is described generally for a water capture structure that is configured to capture wave water lapping over at least one wall of the water capture structure. The at least one wall extends at least above a nominal surface water level and at least one conduit extends downward from the water capture structure. The at least one conduit has a length extending to a depth at which at least one property of water at the depth differs substantially from that of water at the surface. The at least one conduit is configured to provide thermal energy to water outside of the at least one conduit. The at least one conduit has at least one conduit wall. | 12-02-2010 |
| 20100301094 | Surgical stapling instrument with chemical sealant - Embodiments include a surgical device and a method. An embodiment of the surgical instrument includes at least one grasping jaw, the at least one grasping jaw being adapted to deliver surgical staples by a force generated from a force generator mechanism that is contained within the at least one grasping jaw or is in a proximity to the at least one grasping jaw. Another embodiment includes at least one grasping jaw, at least one actuation mechanism adapted to deliver surgical staples, the actuation mechanism being located in a proximity to or contained within the at least one grasping jaw, the surgical staples containing at least one shape-transforming material, at least one sensor, at least one chemical tissue sealant and at least one cutter. A method includes: grasping a body tissue with at least one grasping jaw, adjusting a configuration of the grasping in response to a signal or a datum or an image, and releasing a surgical staple/fastener in response to the signal, datum or image. | 12-02-2010 |
| 20100308295 | Deletable nanotube circuit - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 12-09-2010 |
| 20100320366 | Beam power with beam redirection - A beam power source transmits a signal indicating power availability, receives a request for power in response, and beams power in response to the request. | 12-23-2010 |
| 20110011611 | Polarized lightning arrestors - Systems and methods for dynamically defending a site from lightning strikes are provided. The systems and methods involve dynamically altering electrostatic fields above the site and/or dynamically intervening in lightning discharges processes in the vicinity of the site. | 01-20-2011 |
| 20110011622 | Maintaining insulators in power transmission systems - An electrical power transmission system includes electrical insulators arranged to electrically isolate live power lines. Surface reconditioning units are incorporated or integrated in the insulator structures. A sensor arrangement determines surface conditions of the electrical insulators in use to isolate live power lines. In response, the surface reconditioning units automatically recondition the surfaces of the in-service electrical insulators if appropriate for maintaining the electrical insulators in healthy state. | 01-20-2011 |
| 20110012436 | Systems and methods for assessing standoff capabilities of in-service power line insulators - An electrical power transmission system includes electrical insulators arranged to electrically isolate live power lines. Measurement devices are physically incorporated or integrated in the insulator structures. The measurement devices measure and report insulator properties during live wire conditions. | 01-20-2011 |
| 20110012437 | Maintaining insulators in power transmission systems - An electrical power transmission system includes electrical insulators arranged to electrically isolate live power lines. Surface reconditioning units are incorporated or integrated in the insulator structures. A sensor arrangement determines surface conditions of the electrical insulators in use to isolate live power lines. In response, the surface reconditioning units automatically recondition the surfaces of the in-service electrical insulators if appropriate for maintaining the electrical insulators in healthy state. | 01-20-2011 |
| 20110012583 | Use pairs of transformers to increase transmission line voltage - A smart link in a power delivery system includes an insulator, which electrically isolates a power line, and a switchable conductance placed in parallel with the insulator. The switchable conductance includes switchgear for sourcing, sinking, and/or dispatching real and/or reactive power on the power line to dynamically in response to dynamic loading, transient voltages and/or currents, and phase conditions or other conditions on the power line. | 01-20-2011 |
| 20110012615 | Systems and methods for assessing standoff capabilities of in-sevice power line insulators - An electrical power transmission system includes electrical insulators arranged to electrically isolate live power lines. Measurement devices are physically incorporated or integrated in the insulator structures. The measurement devices measure and report insulator properties during live wire conditions. | 01-20-2011 |
| 20110012616 | Systems and methods for assessing standoff capabilities of in-service power line insulators - An electrical power transmission system includes electrical insulators arranged to electrically isolate live power lines. Measurement devices are physically incorporated or integrated in the insulator structures. The measurement devices measure and report insulator properties during live wire conditions. | 01-20-2011 |
| 20110013323 | Systems and methods for grounding power line sections to clear faults - Systems and methods for dynamically clearing faults in a power transmission line involve automatically terminating ends of a section of the power line while preserving electrical and/or physical continuity of the power line. The terminating of the ends is reversed at about voltage zero-crossings in the power line to clear a fault. | 01-20-2011 |
| 20110013324 | Systems and methods for grounding power line sections to clear faults - Systems and methods for dynamically clearing faults in a power transmission line involve automatically terminating ends of a section of the power line while preserving electrical and/or physical continuity of the power line. The terminating of the ends is reversed at about voltage zero-crossings in the power line to clear a fault. | 01-20-2011 |
| 20110013331 | Polarized lightning arrestors - Systems and methods for dynamically defending a site from lightning strikes are provided. The systems and methods involve dynamically altering electrostatic fields above the site and/or dynamically intervening in lightning discharges processes in the vicinity of the site. | 01-20-2011 |
| 20110013332 | Polarized lightning arrestors - Systems and methods for dynamically defending a site from lightning strikes are provided. The systems and methods involve dynamically altering electrostatic fields above the site and/or dynamically intervening in lightning discharges processes in the vicinity of the site. | 01-20-2011 |
| 20110013333 | Polarized lightning arrestors - Systems and methods for dynamically defending a site from lightning strikes are provided. The systems and methods involve dynamically altering electrostatic fields above the site and/or dynamically intervening in lightning discharges processes in the vicinity of the site. | 01-20-2011 |
| 20110013336 | Polarized lightning arrestors - Systems and methods for dynamically defending a site from lightning strikes are provided. The systems and methods involve dynamically altering electrostatic fields above the site and/or dynamically intervening in lightning discharges processes in the vicinity of the site. | 01-20-2011 |
| 20110027621 | Instrumented fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface and one or more sensors configured to detect an operating condition of the device. Fluid-directing structures may modulate flow or retain fluid in response to the sensors. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027624 | Fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface, which may employ a surface energy effect to maintain a position of the fluid surface and/or to modulate flow within the fluid. Fluid-directing structures may also modulate flow or retain fluid in a predetermined pattern. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027627 | Fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface, which may employ a surface energy effect to maintain a position of the fluid surface and/or to modulate flow within the fluid. Fluid-directing structures may also modulate flow or retain fluid in a predetermined pattern. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027628 | Instrumented fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface and one or more sensors configured to detect an operating condition of the device. Fluid-directing structures may modulate flow or retain fluid in response to the sensors. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027629 | Instrumented fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface and one or more sensors configured to detect an operating condition of the device. Fluid-directing structures may modulate flow or retain fluid in response to the sensors. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027633 | Instrumented fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface and one or more sensors configured to detect an operating condition of the device. Fluid-directing structures may modulate flow or retain fluid in response to the sensors. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027637 | Fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface, which may employ a surface energy effect to maintain a position of the fluid surface and/or to modulate flow within the fluid. Fluid-directing structures may also modulate flow or retain fluid in a predetermined pattern. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027638 | Fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface, which may employ a surface energy effect to maintain a position of the fluid surface and/or to modulate flow within the fluid. Fluid-directing structures may also modulate flow or retain fluid in a predetermined pattern. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110027639 | Fluid-surfaced electrode - An electrochemical device (such as a battery) includes at least one electrode having a fluid surface, which may employ a surface energy effect to maintain a position of the fluid surface and/or to modulate flow within the fluid. Fluid-directing structures may also modulate flow or retain fluid in a predetermined pattern. An electrolyte within the device may also include an ion-transport fluid, for example infiltrated into a porous solid support. | 02-03-2011 |
| 20110028798 | Electronically initiating an administration of a neuromodulation treatment regimen chosen in response to contactlessly acquired information - Described embodiments include a system, and a method. A described method includes acquiring electronic data indicative of a property of a mammal without making physical contact with the mammal. The method also includes extracting digital information indicative of a physiological characteristic of the mammal from the electronic data indicative of the property of the mammal. The method further includes choosing from an electronically accessible treatment database a neuromodulation treatment regimen for administration to the mammal in response to the information indicative of a physiological characteristic of the mammal. The method also includes electronically initiating an administration of the chosen neuromodulation treatment regimen to a nervous system component of the mammal. | 02-03-2011 |
| 20110028799 | Broadcasting a signal indicative of a disease, disorder, or symptom determined in response to contactlessly acquired information - Described embodiments include a system, and a method. A described system includes a sensor device operable to detect a property of a mammal without a direct physical contact with the mammal. The system also includes a patient assessment device operable to evaluate the detected property of the mammal for an indicator of a disease. The system further includes a patient information device including a computer-readable medium, and configured to maintain and to provide access to information corresponding to the indication of the disease. The system further includes a transmitter device operable to broadcast a signal indicative of the disease. | 02-03-2011 |
| 20110029038 | Determining a neuromodulation treatment regimen in response to contactlessly acquired information - Described embodiments include a system, an apparatus, and a method. A described system includes a sensor device configured to sense a property of a mammal without physically contacting the mammal. The system also includes a signal generator configured to generate a signal indicative of the sensed property of the mammal. The system further includes a treatment decision device configured to determine in response to the signal indicative of the sensed property of the mammal a neuromodulation treatment regimen for administration to a nervous system component of the mammal. The system also includes a computer-readable medium configured to maintain and to provide access to information corresponding to the determined neuromodulation treatment regimen. | 02-03-2011 |
| 20110029044 | Stimulating a nervous system component of a mammal in response to contactlessly acquired information - Described embodiments include a system, an apparatus, and a method. A described system includes a sensor device configured to sense a property of a mammal without physically contacting the mammal. The system also includes a signal generator configured to generate a signal indicative of the sensed property of the mammal. The system further describes a neuromodulation device configured to output a stimulus operable to modulate a nervous system component of the mammal in response to the signal indicative of the sensed property of the mammal. | 02-03-2011 |
| 20110029170 | System for selective vehicle operation modes - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029171 | Selective control system for vehicle operating parameters - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029173 | Hybrid vehicle qualification for preferential result - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that may be subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. A further aspect may provide correlation between a selective operation mode of an electric/combustion hybrid vehicle during an applicable travel period and a preferred consequential result available to a qualified recipient associated with the hybrid vehicle. | 02-03-2011 |
| 20110029181 | Selective control of an optional vehicle mode - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. | 02-03-2011 |
| 20110029182 | Vehicle system for varied compliance benefits - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029187 | Promotional correlation with selective vehicle modes - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029188 | Remote processing of selected vehicle operating parameters - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029189 | Promotional correlation with selective vehicle modes - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029190 | Remote processing of selected vehicle operating parameters - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029192 | Selective implementation of an optional vehicle mode - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029255 | Drinking vessels and related systems and methods - Embodiments disclosed herein are directed to systems configured to determine an amount of alcohol in an alcohol-containing liquid discharged from a drinking vessel or an amount of the alcohol-containing liquid discharged from the drinking vessel, drinking vessels configured to measure alcohol content or other property of an alcohol-containing liquid held therein, other related components such as mat devices that facilitate determining the amount, and related methods. The systems, drinking vessels, and methods disclosed herein facilitate determination of an amount of alcohol in an alcohol-containing liquid discharged from a drinking vessel or an amount of alcohol-containing liquid discharged from the drinking vessel, which may be indicative of an amount of alcohol consumed by a drinker. | 02-03-2011 |
| 20110029356 | Selective control of an optional vehicle mode - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. | 02-03-2011 |
| 20110029357 | Promotional correlation with selective vehicle modes - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 02-03-2011 |
| 20110029358 | Promotional incentives based on hybrid vehicle qualification - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that may be subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. A further aspect may provide correlation between a selective operation mode of an electric/combustion hybrid vehicle during an applicable travel period and a preferred consequential result available to a qualified recipient associated with the hybrid vehicle. | 02-03-2011 |
| 20110034908 | Device for actively removing a target component from blood or lymph of a vertebrate subject - Devices, systems, and methods are disclosed herein for modulating the levels of one or more target components in the blood and/or lymph of a vertebrate subject for treatment of a disease or condition in the vertebrate subject. An implantable device is provided which includes a body defining at least one lumen configured for fluid flow; at least one first reservoir in communication with at least one lumen; one or more energy sources configured to provide energy to elicit one or more signal responses associated with one or more labels that bind to one or more target components in one or more of blood fluid or lymph fluid of the vertebrate subject; one or more sensors configured to detect the one or more signal responses associated with one or more labeled target components; and one or more reactive components in communication with the at least one lumen for release responsive to the one or more sensors. | 02-10-2011 |
| 20110051876 | Nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system - Illustrative embodiments provide a nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system. | 03-03-2011 |
| 20110051877 | Nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system - Illustrative embodiments provide a nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system. | 03-03-2011 |
| 20110051881 | Nuclear fission reactor, vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system - Illustrative embodiments provide a nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system. | 03-03-2011 |
| 20110058638 | Nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system - Illustrative embodiments provide a nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system. | 03-10-2011 |
| 20110067216 | Method of retrofitting an engine - A converter converts mechanical energy of a piston to and from electrical energy during each piston cycle. | 03-24-2011 |
| 20110070153 | Artificial cells - The present disclosure relates to various embodiments associated with artificial cells, particularly artificial antigen presenting cells, methods of making the same, methods of administering the same, computer systems relating thereto, computer-implemented methods relating thereto, and associated computer program products. | 03-24-2011 |
| 20110070154 | Artificial cells - The present disclosure relates to various embodiments associated with artificial cells, particularly artificial antigen presenting cells, methods of making the same, methods of administering the same, computer systems relating thereto, computer-implemented methods relating thereto, and associated computer program products. | 03-24-2011 |
| 20110077805 | Selective implementation of an optional vehicle mode - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 03-31-2011 |
| 20110077806 | Selective implementation of an optional vehicle mode - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a preferred consequential result related to a selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 03-31-2011 |
| 20110077807 | Vehicle system for varied compliance benefits - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 03-31-2011 |
| 20110077808 | Vehicle system for varied compliance benefits - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 03-31-2011 |
| 20110082412 | Device for actively removing a target component from blood or lymph of a vertebrate subject - Devices, systems, and methods are disclosed herein for modulating the levels of one or more target components in the blood and/or lymph of a vertebrate subject for treatment of a disease or condition in the vertebrate subject. An implantable device is provided which includes a body defining at least one lumen configured for fluid flow; at least one first reservoir in communication with at least one lumen; one or more energy sources configured to provide energy to elicit one or more signal responses associated with one or more labels that bind to one or more target components in one or more of blood fluid or lymph fluid of the vertebrate subject; one or more sensors configured to detect the one or more signal responses associated with one or more labeled target components; and one or more reactive components in communication with the at least one lumen for release responsive to the one or more sensors. | 04-07-2011 |
| 20110087399 | Promotional correlation with selective vehicle modes - Exemplary methods, systems and components enable selective control of an operational mode for a vehicle that is subject to an administrative standard. In some instances a qualified person or entity may attain a possible consequential result related to a user-selected vehicle operation mode that may involve a vehicle operation paradigm and/or a vehicle travel route and/or a vehicle travel destination. In some embodiments, implementation of the selected vehicle operation mode may modify a conformity status of the vehicle relative to the administrative standard. Various accessible records may be maintained regarding administrative compliance states and their respective benefits, as well as regarding certification of preferable consequential results available to qualified recipients based on a correlated vehicle operational mode. | 04-14-2011 |
| 20110092961 | Artificial cells - The present disclosure relates to various embodiments associated with artificial cells, particularly artificial antigen presenting cells, methods of making the same, methods of administering the same, computer systems relating thereto, computer-implemented methods relating thereto, and associated computer program products. | 04-21-2011 |
| 20110100014 | Hybrid propulsive engine including at least one independently rotatable propeller/fan - One aspect relates to a hybrid propulsive technique comprising providing at least some first thrust associated with a flow of a working fluid through at least a portion of an at least one axial flow jet engine. The hybrid propulsive technique comprises extracting energy from the working fluid that is at least partially converted into electrical power, and converting at least a portion of the electrical power to torque. The hybrid propulsive technique further comprises rotating an at least one independently rotatable propeller/fan of at least one rotatable propeller/fan assembly at least partially responsive to the converting the at least a portion of the electrical power to torque, wherein the rotating of the at least one independently rotatable propeller/fan of the at least one rotatable propeller/fan assembly is arranged to produce at least some second thrust. | 05-05-2011 |
| 20110104831 | Deletable nanotube circuit - Carbon nanotube template arrays may be edited to form connections between proximate nanotubes and/or to delete undesired nanotubes or nanotube junctions. | 05-05-2011 |
| 20110106354 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, querying a vehicle for a status indicative of combustible fuel utilization in comparison to electricity utilization for the vehicle. | 05-05-2011 |
| 20110106591 | Awarding standings to a vehicle based upon one or more fuel utilization characteristics - A method may include, but is not limited to, receiving at least one of a status indicative of combustible fuel utilization or a status indicative of electricity utilization for a hybrid vehicle and conveying a standing, the standing based upon the at least one of the status indicative of combustible fuel utilization or the status indicative of electricity utilization for the vehicle. | 05-05-2011 |
| 20110117150 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or condition of one or more joints of articulating bone in a mammalian subject. A device is described which includes one or more substrates configured to contact one or more body contours at one or more joints of articulating bone of a mammalian subject; and an applicator supported by the one or more substrates and configured to inject one or more medicaments to one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110117151 | Device,system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to monitor movement of the one or more body contours; and one or more applicators supported by the one or more substrates and configured to respond to the movement of the one or more body contours by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118560 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes an enclosure including one or more sensors, a controller, and one or more applicators configured to surround one or more joints of articulating bone of a mammalian subject, wherein the one or more sensors are configured to detect one or more physiological conditions of the one or more joints of the mammalian subject, and the controller, configured to communicate with the one or more sensors, is configured to activate the one or more applicators, and wherein the one or more applicators are configured to inject one or more medicaments to one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118652 | Device,system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more microjet applicators supported by the one or more substrates and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118653 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes an enclosure including one or more sensors, a controller, and one or more applicators configured to surround one or more joints of articulating bone of a mammalian subject, wherein the one or more sensors are configured to detect one or more physiological conditions of the one or more joints of the mammalian subject, and the controller, configured to communicate with the one or more sensors, is configured to activate the one or more applicators, and wherein the one or more applicators are configured to inject one or more medicaments to one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118656 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more sheaths configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more applicators supported by the one or more sheaths and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118695 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to monitor movement of the one or more body contours; and one or more applicators supported by the one or more substrates and configured to respond to the movement of the one or more body contours by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118696 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or condition of one or more joints of articulating bone in a mammalian subject. A device is described which includes one or more substrates configured to contact one or more body contours at one or more joints of articulating bone of a mammalian subject; and an applicator supported by the one or more substrates and configured to inject one or more medicaments to one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118697 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more microjet applicators supported by the one or more substrates and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110118698 | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more sheaths configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more applicators supported by the one or more sheaths and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject. | 05-19-2011 |
| 20110144566 | Systems, devices, and methods including catheters having an actively controllable therapeutic agent delivery component - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-16-2011 |
| 20110148753 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150167 | Nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system - Illustrative embodiments provide a nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system. | 06-23-2011 |
| 20110150276 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150294 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150295 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150296 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150297 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150298 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150299 | Identifying a characteristic of an individual utilizing facial recognition and providing a display for the individual - A method may include automatically remotely identifying at least one characteristic of an individual via facial recognition; and providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. A system may include a facial recognition module configured for automatically remotely identifying at least one characteristic of an individual via facial recognition; and a display module coupled with the facial recognition module, the display module configured for providing a display for the individual, the display having a content at least partially based on the identified at least one characteristic of the individual. | 06-23-2011 |
| 20110150924 | Device, Method, and system for neural modulation as vaccine adjuvant in a vertebrate subject - A method for enhancing an immune response in a vertebrate subject is described. The method includes providing at least one energy stimulus configured to modulate one or more nervous system components of the vertebrate subject, and administering one or more immunogen to the vertebrate subject, wherein the at least one energy stimulus and the one or more immunogen are provided in a combination and in a temporal sequence sufficient to enhance an immune response in the vertebrate subject. | 06-23-2011 |
| 20110152748 | Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject - A method for enhancing an immune response in a vertebrate subject is described. The method includes providing at least one energy stimulus configured to modulate one or more nervous system components of the vertebrate subject, and administering one or more immunogen to the vertebrate subject, wherein the at least one energy stimulus and the one or more immunogen are provided in a combination and in a temporal sequence sufficient to enhance an immune response in the vertebrate subject. | 06-23-2011 |
| 20110152750 | Systems devices, and methods including catheters configured to monitor and inhibit biofilm formation - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110152751 | Systems, devices, and methods including catheters having UV-Energy emitting coatings - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110152752 | Systems, devices, and methods including catheters having components that are actively controllable between transmissive and reflective states - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110152789 | Systems, devices, and methods including catheters having components that are actively controllable between two or more wettability states - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110152790 | Systems, devices, and methods including catheters having self-cleaning surfaces - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110152978 | Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110160643 | Systems, devices, and methods including catheters having acoustically actuatable waveguide components for delivering a sterilizing stimulus to a region proximate a surface of the catheter - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-30-2011 |
| 20110160644 | Systems, devices, and methods including catheters configured to release ultraviolet energy absorbing agents - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-30-2011 |
| 20110160681 | Systems, devices, and methods including catheters having light removable coatings based on a sensed condition - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-30-2011 |
| 20110166536 | Substrates for nitric oxide releasing devices - The present disclosure relates to substrates associated with nitric oxide. | 07-07-2011 |
| 20110166937 | Media output with micro-impulse radar feedback of physiological response - A system and method for providing media and/or advertising content determines content and/or parameters responsive to physical and/or physiological information about a viewer detected by a micro-impulse radar (MIR). | 07-07-2011 |
| 20110166940 | Micro-impulse radar detection of a human demographic and delivery of targeted media content - A micro-impulse radar (MIR) may be configured to provide information about at least one person in a region. A media output device may be driven responsive to the information to output media content to the at least one person. | 07-07-2011 |
